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resumo 
 
 
A resistência a antifúngicos é, hoje em dia, um problema sério a nível clínico, 
pelo que há necessidade de descobrir novos alvos que possibilitem o 
desenvolvimento de novos antifúngicos. Investigação a decorrer no nosso 
laboratório indica que a ambiguidade no reconhecimento de codões em 
Candida albicans, um patogénio humano, acelera a resistência a antifúngicos. 
O presente trabalho teve como objectivo elucidar se a ambiguidade em 
leveduras não patogénicas aumenta a resistência a antifúngicos. Para tal foi 
induzida artificialmente ambiguidade no reconhecimento de diferentes codões 
em Saccharomyces cerevisiae. As estirpes resultantes possuem um plasmídeo 
de replicação reduzida contendo um tRNAUGA
Ser
 de C. albicans sujeito a 
mutagénese dirigida, de modo a mutar o anticodão. Os novos anticodões 
reconhecem codões de diferentes aminoácidos mas o tRNA mantém os 
elementos de reconhecimento, sendo acilado com serina. Os tRNAs mutantes 
vão competir com os nativos, formando-se um proteoma estatístico. Para 
verificar se estas estirpes apresentam um fenótipo mais vantajoso em resposta 
a variados antifúngicos, foram  expostas a diferentes classes dos mesmos. 
Adicionalmente, foram analisados microarrays de estirpes não expostas a 
qualquer stress adicional, de modo a perceber se as mesmas apresentam já 
tendência para responderem de modo diferente perante os diferentes 
antifúngicos. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
keywords 
 
mistranslation, antifungal drug resistance, transfer RNA 
 
abstract 
 
Antifungal drug resistance has become a severe clinical problem and new 
targets for the development of new antifungal drugs need to be discovered. 
Ongoing work in our laboratory indicates that codon mistranslation due to 
codon ambiguity accelerates antifungal drug resistance in the human pathogen 
Candida albicans. The present work aimed to elucidate if non pathogenic 
yeasts behave similarly. Therefore, mistranslation was artificially induced in 
Saccharomyces cerevisiae strains by the expression of chimeric tRNAs. Each 
of the constructed strains carried a low-copy number plasmid, containing a C. 
albicans tRNAUGA
Ser
 gene, whose anticodon was changed by site-directed 
mutagenesis, in order to replace it by several other anticodons. As the identity 
elements of the tRNA remained unchanged it was still acylated with serine. 
These mutant tRNAs are expected to compete with the native ones and have 
an impact on the proteome. To verify if mistranslation leads to an 
advantageous phenotype regarding antifungal drug resistance, cells were 
exposed to different antifungals. Additionally, microarray analyses were 
performed on non-exposed mutant strains in order to detect a possible pre-
disposition to resist antifungal exposure. 
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Thesis outline 
 
This work was aimed to elucidate if mistranslation due to codon ambiguity 
accelerates antifungal drug resistance in Saccharomyces cerevisiae, as it was 
previously tested for Candida albicans (data not published). 
S. cerevisiae is a good model organism to study the antifungal action upon 
mistranslation. It is well characterized, its genome was fully sequenced and it is 
closely related to C. albicans, a major opportunistic pathogen. 
Experiments were performed using mutant S. cerevisiae strains, in which 
artificial mistranslation was induced by the expression of a mutant Candida 
albicans serine tRNA. This mutant tRNA was previously subjected to site-directed 
mutagenesis in order to change its anticodon to several other anticodons. The 
anticodon of serine-tRNAs is not an identity element and therefore, aminoacylation 
is not compromised. These mutant tRNAs will compete with the native ones by 
recognizing different amino acid codons but inserting always serine into the 
nascent polypeptide. A fraction of mutant proteins will not fold or will be unstable. 
These unstable proteins are expected to either unfold, have impaired function or 
eventually gain new functions. As each of the different strains carries a unique 
amino acid substitution (e.g. replacement of threonine by serine), severe 
consequences are expected to happen especially when very different chemically 
and structurally amino acids are exchanged. 
 First, we accessed the growth rate of the mistranslating strains. Then, an 
evolution experiment was carried out in order to investigate if mistranslation 
accelerates antifungal drug resistance and if translational stress-induced 
mutagenesis (TSM) occurs also in eukaryotes. To check for differences in 
antifungal drug resistance susceptibility tests were performed using different 
classes of antifungals (e.g. azoles, echinocandins, pyrimidine analogs and 
polyenes). Additionally, a long term experiment was performed using these strains, 
aimed to answer the question whether mistranslation over time increases mutation 
rate on a genome wide view. Therefore, whole genome sequencing will be applied 
in order to check for single nucleotide polymorphisms, indels and chromosomal 
rearrangements, among others. Finally, microarray analyses of the mistranslating 
strains were used to support the data obtained in a phenomics study in which 
several antifungals and translation inhibitors were used. 
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Introduction 
 
 
1. The genetic code 
 
The genetic code represents a well thought but degenerate system to 
translate nucleic acid sequences into proteins. Initially, 20 amino acids were 
described (Crick, 1966b), but a few years later, selenocysteine and pyrrolysine 
were discovered (Bock et al., 1991; Hao et al., 2002). 
DNA sequences consist of four deoxyribonucleotides which can be purines 
- adenine (A) and guanosine (G) – or pyrimidines – cytosine (C) and thymine (T). 
In eukaryotes, these sequences are transcribed into non processed messenger 
RNAs (mRNA) by RNA polymerase II  and after maturation are translated into 
proteins by ribosomes. mRNA sequences consist of four ribonucleotides - adenine 
(A), uridine (U), guanosine (G) and cytosine (C) - which are organized in triplets, 
enabling a set of 43 = 64 possible codons. Those codons are either specifically 
assigned to amino acids or lead to translation termination (figure 1). Furthermore, 
the genetic code is considered to be degenerate, as with the exception of 
methionine and tryptophan, every amino acid can be decoded by two or more 
synonymous codons. Those codons similar to each other are assigned to 
chemically similar amino acids. This biased display of triplets is very important in 
order to reduce the incorporation of dissimilar amino acids into a protein. Hence a 
near cognate amino acid can be misincorporated but rarely will a non-cognate 
one. Due to their chemical differences the introduction of dissimilar amino acids 
could cause major consequences (e.g. improper protein folding). Another 
important feature is that most synonymous codons have the same ribonucleotide 
at the same position, usually the second one. Such feature also contributes to 
reduce the consequences of misincorporation as errors happen more easily by 
misreading of the third ribonucleotide position known as the wobble position.  
Actually, the wobble hypothesis predicted that ribonucleotides could be 
displaced and form a non-Watson-Crick base pair (Crick, 1966a). Recent research 
has confirmed this statement, verifying that the wobble position often contains a 
modified base, which can have more than one correspondent ribonucleotide (Agris 
et al., 2007). 
Another aspect to be considered is the correlation between sets of codons 
and the two groups of tRNA-aminoacyl synthetases. Group I synthetases deal with 
codons containing uridine in the second position (with the exception of the 
phenylalanine codon), while group II synthetases handle all codons containing 
cytosine in this position (Wetzel, 1995). 
Thus, the organization of the genetic code contributes to the improvement 
of translation accuracy. 
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1.1 Transfer RNA 
 
Besides the wobble hypothesis, Crick postulated his adaptor hypothesis, 
which states that adaptor molecules possibly link nucleotides to amino acids(Crick, 
1958). These adaptor molecules, which recognize codons in the mRNA were 
discovered to be transfer RNAs (tRNA). Due to the wobble position mentioned 
above, tRNAs exist in isoacceptor families, and each family is recognized by a 
cognate aminoacyl-tRNA synthetase (aaRS).  
tRNAs‟ secondary structure resembles a cloverleaf and their tertiary 
structure is L-shaped. The cloverleaf shape forms due to base pairing and consists 
of a stem with a loose 3‟-CCA end, called acceptor stem as it binds the 
corresponding amino acid, and three stem loops: the D loop, the anticodon loop 
and the T loop. Some tRNAs have an extra variable loop located between the 
anticodon and the T loops. Regarding the tertiary structure, the anticodon is 
located on the first major domain of the “L” shape, while on the second domain the 
correspondent amino acid is attached (figure 2). 
In eukaryotes, post-transcriptional processing of tRNAs is required to allow 
fine tuning of structure and identity in order to obtain diverse tRNA types (Hopper 
et al., 2010). Part of this process is the customization of nucleotides in specific 
positions. Some modifications are quite complex, requiring more than one 
modifying enzyme. A well known example is the ubiquitous pseudouridine (ᴪ), the 
first discovered tRNA modification. So far, 81 modifications concerning tRNA are 
known and from those, 47 belong to the Eukarya domain (the RNA modification 
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Figure 1 - Standard genetic code: Pink-polar uncharged; blue- positively charged; 
green – negatively charged; orange – non polar. 
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database). These contribute to the stability and recognition of the carrying 
molecule, and tend to be conserved within phylogenetic domains. In particular, 
they contribute to tRNA folding, Mg2+ binding, intron removal, protein recognition, 
codon recognition and fidelity of the translational reading frame (Agris, 2008). 
Variation in modification level appears along with disease, under exposure to 
stresses such as starvation and drug exposure, and seem to be age and 
localization dependent (Dirheimer et al., 1995). 
Besides such nucleoside modifications, transfer RNAs are subjected to 
further post transcriptional processing, such as splicing and trimming of 5‟- and 3‟-
ends by specific RNAses (reviewed by Hopper et al., 2010; Nakanishi and Nureki, 
2005). Unlike in many bacteria, eukaryote tRNA genes do not encode the 3‟-CCA 
tail, thus, it has to be added enzymatically. An important role of this loose end is to 
protect the tRNA from degradation due to its function as an anti determinant 
against the 3‟end ribonucleases (Phizicky and Hopper, 2010).  
 
 
 
 
 
 
 
tRNA identification by aaRS owes less to modified nucleotides than to 
structural elements along the tRNA.  However, if located at the wobble position, 
the modified residue can contribute both for precise codon-anticodon pairing and 
the recognition of the tRNA. One example is the hypermodified nucleoside 
mnm5s2U at the wobble position of tRNALys and tRNAGlu (Nakanishi and Nureki, 
2005). tRNAs may interact with aaRSs at several regions (e.g. Lenhard et al., 
1999; McClain et al., 1998; Sekine et al., 1996; Senger et al., 1995), but mainly 
with the discriminator base (position 73), the acceptor stem pairs 1-72, 2-71 and 3-
70, and the anticodon (McClain, 1993). These identity elements serve not only 
specific recognition purposes but also can inhibit aminoacylation by non-cognate 
aaRSs (antideterminants or negative elements) (McClain, 1993). 
Figure 2 - The structure and domains of tRNA. The cloverleaf secondary structure (A) is color coded to identify 
the structural domains of the crystal structure: amino acid accepting stem, or aminoacyl-stem (AA) in red; 
dihydrouridine stem and loop domain (DSL) in black; anticodon stem and loop domain (ASL) in green; variable 
or extra loop (EL) in orange; and the ribothymidine, or TYC, stem and loop (TSL) in light blue. The positions of 
the (almost) invariant U33 and the amino acid accepting 3‟-terminus (C74, C75 and A76) are shown. The 
three-dimensional structure of tRNA is represented by the crystallographic structure of yeast tRNA
Phe
(B). 
Adapted from Agris (2004). 
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1.2 Aminoacyl tRNA synthetases 
 
Aminoacyl tRNA synthetases catalyze the 3‟- esterification of tRNAs with 
their cognate amino acid. Esterification mostly happens in a direct way, according 
to the following reactions: 
 
Amino acid + ATP + aaRS    aaRS(amino acid)-AMP + PPi 
aaRS(amino acid)-AMP + tRNA    aaRS + (amino acid)-tRNA + AMP 
 
Although similar in action aaRSs can be divided into two evolutionary 
distinct classes. Each class gathers those containing a certain structural motif in 
their active site. Even though not all synthetases have been extensively studied, 
these two motifs seem to result in two different ways of binding ATP and 
approaching the cognate tRNA: Class I binds ATP in an extended conformation 
and approaches the tRNA‟s acceptor stem from its minor groove side, and class II 
binds ATP in a bent conformation and approaches the tRNA‟s acceptor stem from 
the major groove side (Ibba and Soll, 2000). Only LysRS can be found in both 
classes, depending on the organism. 
Although evolutionary distinct, it has been suggested by Rodin and Ohno 
(1995) that they could be complementary to each other, giving rise to the idea that 
in early genomes both strands of RNA were used for protein synthesis. Further, 
each class can be divided in three subclasses (a, b, and c) representing closer 
related enzymes (Schimmel, 2008). 
 
 
  
 Class I Class II 
a 
MetRS SerRS 
ValRS ThrRS 
LeuRS AlaRS 
IleRS GlyRS 
CysRS ProRS 
ArgRS HisRS 
b 
GluRS AspRS 
GlnRS AsnRS 
LysRS-1 LysRS-2 
c 
TyrRS PheRS 
TrpRS  
 
 
Figure 3 - Classes and subclasses of aminoacyl tRNA synthetases. Subclasses include enzymes 
that are most closely related to each other in their sequences. Significantly, the subclasses also 
group aminoacyl tRNA synthetases according to their amino acid chemical types. Adapted from 
Schimmel (2008). 
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2. Protein translation in Eukaryotes 
 
 
Messenger RNA (mRNA) is subjected to maturation resulting in a ready-to-
go template that can be frequently used by the translation machinery, as long as it 
remains stable and is needed. The translation machinery consists of cytoplasmic 
ribosomes,  tRNAs and translational factors, and is assisted by aaRS. Eukaryotic 
ribosomes are large complexes of proteins and ribosomal RNA (rRNA). They can 
be divided into a large 60S and a small 40S subunit. These two subunits bind to 
each other during translation. The complete ribosome 80S permits the binding of 
three tRNAs, whose binding sites are located on the 40S subunit. These are called 
aminoacyl (A site), peptidyl (P site) and exit (E site) sites. 
Protein translation can be divided in three steps: initiation, elongation and 
termination.  These steps are followed by the recycling of the ribosome.  
 
 
2. 1 Initiation 
 
Initiation is assisted by the initiation factors, which interact with each other, 
resulting in a solid and stable initiation complex, able to bind strongly to the 
mRNA. Many of these factors are also macrocomplexes. 
Initiation requires the formation of a ternary complex, which is formed by the 
initiator transfer RNA bound to methionine (Met-tRNAi
Met), the eukaryotic initiation 
factor 2 (eIF2) and GTP. eIF2 is assisted by eIF2B which recycles GDP back to 
GTP. This complex binds to the small ribosomal subunit (40S) and to eIF1, 1A and 
3, resulting in a larger complex, the 43S. These factors appear to help scanning 
the mRNA (eIF1 and 1A) and to avoid premature binding of the large ribosomal 
subunit (eIF3) (reviewed by Kapp and Lorsch, 2004). 
Before the 43S complex attaches to the 5‟end of the mRNA, forming the 
48S complex, unwinding of the mRNA‟s secondary and tertiary structure in 5‟-
untranslated region (UTR) takes place and an anchor is assembled. The 
unwinding seems to be performed by the helicase eIF4A, stimulated by eIF4B 
(Grifo et al., 1982; Lawson et al., 1989; Ray et al., 1985; Rozen et al., 1990). The 
anchor assembly seems to be accomplished by the binding of eIF4E to the  5‟ 7-
methylguanosine cap. The anchor eIF4E, together with eIF4A bind to eIF4G. 
These three factors together form the eIF4F complex. eIF4G functions like a hub 
and is thought to be very important in unusual cases of initiation, such as the 
absence of the 5‟ cap, the poly A tail, or both simultaneously, and in the presence 
of an internal ribosome-entry site (IRES) mediated translation which is cap-
independent (Holcik and Sonenberg, 2005; Johannes et al., 1999). Finally, the 
48S complex can start scanning the 5‟UTR for the initiation codon (AUG). 
With the localization of the initiation codon, the 60S ribosomal subunit, 
binds to the small subunit, assisted by eIF5B. As ligation happens, eIF 1, 1A, 3 
and 5 are released. Premature association of ribosomal subunits is thought to be 
blocked in part by the binding of eIF6 to the 60S. 
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2.2 Elongation 
 
After the binding of the met-tRNAi
Met anticodon to the initiation codon (AUG) 
elongation starts. Met-tRNAi
Met binds at the P site while the following tRNAs bind to 
the A site of the ribosome. Elongation ternary complexes bind to the elongation 
factor eEF1A instead of eIF2. eEF1A triggers GTP hydrolysis, and eEF1AGDP 
releases the aminoacyl tRNA. Codon-anticodon base pairing and the GTP 
hydrolysis by eEF1A are part of the quality control steps (see below). The 
formation of a peptide bond between the incoming amino acid and the peptidyl 
aminoacyl-tRNA is carried out by the ribosomal peptidyl transferase center. Then, 
translocation takes place with the deacylated tRNA moving to the E site. During 
Figure 4 - Translation initiation in eukaryotes (Holcik and Sonenberg, 2005).
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translocation the tRNA passes through a hybrid state in which it is present in both 
sites. The same happens to the tRNA at the A site by first translocating its 
acceptor stem to the P site and only then the anticodon end. Translocation is 
possible due to GTP hydrolysis stimulated by the factor of the eEF2GDP 
complex. After translocation the A site is free for the next aa-tRNA to bind. 
However, eEF1AGDP has to be recycled and this is accomplished by the eEF1B 
complex, consisting of eEF1Bα and eEF1Bβ (Kapp and Lorsch, 2004). During 
translation the three ribosome sites will always be occupied. Once a deacylated 
tRNA is released from the E site, a new ternary complex binds to the A site. This 
process is repeated until a stop signal appears. 
Particularly, in fungi a third factor, eEF3, exists which was shown to be 
essential in yeast survival (Qin et al., 1990). It interacts with eEF1A (Kovalchuke et 
al., 1998), and is required for every round of peptide bond formation. Two possible 
roles are described for eEF3: a) to aid in the release of the deacylated tRNA from 
the E site and b) to increase efficiency in the binding of eEF1AGTPaa-tRNA to 
the A site (Trianaalonso et al., 1995). 
  
 
 
 
 
 
 
It was previously demonstrated that the rate-limiting step in elongation is 
tRNA selection and that different tRNAs exist in different concentrations leading to 
variation in the translation rate along the mRNA (Varenne et al., 1984). Thus, to 
maintain translation at a specific relevant rate (Reynolds et al., 2010) it is 
important that a set of correctly acylated tRNAs is available at any time. Otherwise 
the elongation complex will get stalled and/or a near-cognate tRNA, more 
 
Figure 5 - Translation elongation in eukaryotes. Adapted from Kapp and Lorsch (2004) 
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abundant at that moment, may eventually take the correct one‟s place, resulting in 
a mistranslated protein. 
 
 
 
2.3 Termination 
 
Once a stop signal enters the A site the release of the peptide is initiated. 
There are no cognate tRNAs to decode stop signals. Instead, a release factor with 
a similar 3-D structure binds to the ribosome. Only two release factors exist in 
eukaryotes. eRF1 decodes all three stop signals (UAA, UAG or UGA) while eRF3 
is discussed to be a GTPase that stimulates the release of eRF1 from the 
ribosome, leading to consequent peptidyl tRNA hydrolysis. eRF3 is essential in 
eukaryotes and its interaction with eRF1 leads to an optimal termination efficiency 
in S. cerevisiae (Kapp and Lorsch, 2004). 
 
 
 
 
 
 
 
 
2.4 Recycling and re-initiation 
 
After termination the ribosomes can be used again for another translation 
round on the same mRNA (re-initiation) or reassembled on a new mRNA 
(recycling). Regarding recycling it is known that a post-termination complex 
(PoTC) remains, consisting at least of mRNA, tRNA and ribosome. Recently, eIF3, 
eIF1 and eIF1A have been suggested to cooperatively disassemble PoTCs into 
 
Figure 6 - Translation termination and recycling. adapted from Kapp and Lorsch (2004). 
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free 60S subunits and mRNA and tRNA bound 40S subunits (Pisarev et al., 2007). 
In yeast eEF3 and ATP have been implicated in the disassembly of this complex, 
suggesting that they catalyze the simultaneous split of the ribosomal subunits and 
the detachment of mRNA and deacylated tRNA (Kurata et al., 2010). There is still 
much to unravel about recycling especially concerning which factors are involved 
and how. 
The discovery of the interaction of poly-A binding protein (PABP) with 
eIF4G led to the assumption that mRNA circularizes and re-initiation of translation 
takes place. Hence, after termination, the 40S subunit might not be released, but 
instead transferred back to the 5‟ end via 3‟ and 5‟ translation factors (figure 7) 
(Tarun and Sachs, 1996). 
 
 
 
 
 
 
 
 
  
 
Figure 7 - „Circular‟ or „closed-loop‟ mRNA model showing circularization mediated by poly(A)-
binding protein (PABP) binding to both the poly(A) tail and eIF4G: (i) scanning of the 40S 
containing 43S initiation complex to the initiation codon, (ii) joining of the 60S ribosomal subunit 
to form a translation-competent 80S complex, (iii) protein elongation, (iv) termination of 
translation, and (v) re-initiation. Adapted from Mazumder et al. (2003). 
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3. Mistranslation  
 
 
Translation is the most error-prone step of protein synthesis. The overall 
translational error rate is about 1 in 104 polymerized amino acids  which is 
approximately the sum of transcription (∼10−4), aa-tRNA synthesis (∼10−4), and 
ribosomal decoding  (∼10−4) errors. Mainly for eukaryotes, the known mechanisms 
controlling protein translation are important to avoid wasting energy by producing 
unnecessary amounts of non-functional proteins. Actually, it has been estimated 
that translation can consume up to 50% of the cell‟s energy (Holcik and 
Sonenberg, 2005), and therefore, it is important for cells to have different 
possibilities to control translation (Gebauer and Hentze, 2004; Hinnebusch, 2005). 
In cases of stress global translation can be reduced, while selective translation can 
be activated in order to synthesize specific proteins that aid cell survival. Protein 
synthesis errors can arise from DNA mutations, during transcription and/or 
splicing, during the translation process or even during folding (figure 8). Only 
errors occurring during translation are considered in the following. 
Mistranslation has a plethora of sources and contributes greatly to the 
production of non functional proteins. In general, mammalian cells have proven to 
be more sensitive to mistranslation than bacteria and yeast (Nangle et al., 2006). 
 
 
 
  
 
 
 
 
 
Figure 8 - Sources of errors in eukaryotic protein synthesis. Adapted from Drummond and 
Wilke (2009)  
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3.1 tRNA aminoacylation errors 
 
As mentioned, direct tRNA aminoacylation is a two-step process meticulously 
controlled by aaRS (e.g. “double-sieve” model proposed by Fersht (1977)), but still 
errors can occur at a significant error rate (Reynolds et al., 2010). The errors at 
this stage include: 
1. Editing failures 
2. tRNA misrecognition by aaRS 
3. Amino acid misactivation 
 
1) Editing is needed to amend amino acid misactivation. These types of 
failures are probably due to mutations. To date, the only known case which 
seriously affects mammals is caused by a heritable missense mutation in 
the editing domain of AlaRS in mice (Lee et al., 2006). This enzyme 
mischarges tRNAAla with serine, giving rise to a statistical protein 
population. As a result, the unfolded protein response (UPR) is triggered, 
leading to Purkinje cells (in cerebellum) degeneration and consequently, 
ataxia1. In vitro cultures of human cells, using an editing-defective ValRS 
have also shown increased degradation and apoptosis (Nangle et al., 
2006). Regarding prokaryotic cells, heritable mutations in the editing site of 
an IleRS were verified to result in the induction of error-prone DNA 
polymerases (Bacher and Schimmel, 2007). 
 
2) The structural diversity of different base combinations, and a complex 
network of sequence-specific aaRS-tRNA interactions, sometimes aided by 
binding enhancers, ensures the accurate selection of the cognate tRNA. 
Further, in vivo aaRSs compete for their cognate tRNAs.  For these 
reasons, misrecognition of tRNAs seems to be rare compared to other 
errors and thus, there is no need for proofreading ability. In eukaryotes, 
despite some exceptions, tRNA transcription and maturation occur in the 
nucleus. This “boundary” guarantees to aaRSs that only functional tRNAs 
are exported to the cytoplasm (Ibba and Soll, 1999). 
 
3) Amino acids are very small molecules and therefore pose a challenge to 
aaRSs. For instance, class I synthetases can deal with wrong attached 
amino acids in two ways (Cochella and Green, 2005; Reynolds et al., 
2010): 
 
 Pre-transfer (before the linkage to the tRNA): First, the correct amino 
acid has to be selected by the aaRS. This is a grand challenge as some 
of them have similar chemical or physical properties and hence, must 
be distinguished mainly by their side chains. During selection amino 
acids with larger side chains are easily discarded but those with smaller 
ones can pass through the “sieve”. If the aaRS detects the erroneous 
selection, the misactivated amino acid is transferred to a second 
catalytic site, called editing-site (second sieve) in which, in contrast to 
                                                          
1
 Ataxia is a non-specific clinical manifestation implying dysfunction of the parts of the nervous 
system that coordinate movement, such as the cerebellum. 
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the smaller misactivated amino acid, the cognate amino acid does not 
fit. There, the misactivated amino acid is hydrolyzed. 
 Post transfer (after linkage): If the aaRS does not detect the error, the 
amino acid will be linked to the tRNA, which still might be correctly 
selected due to its numerous identification elements. Misacylation can 
also be detected by the aaRS followed by the hydrolysis of the ester 
bound between the 3‟-CCA end of the tRNA and the amino acid in the 
editing site. If the misacylated tRNA is released it might be re-sampled 
by the aaRS or recognized by trans-acting factors (trans editing), such 
as D-aminoacyl-tRNA deacylases. 
 
 
 
 
 
 
 
If all of these check points fail, there is still one last possibility of preventing the 
use of a misacylated tRNA during the formation of the ternary complex with GTP 
and eIF2 (or eEF1A). Both amino acid and tRNA contribute to the binding affinity 
to the ternary complex. If a non-cognate amino acid is attached to the tRNA, this 
binding affinity decreases immensely (up to 700-fold) (Asahara and Uhlenbeck, 
2002). 
Although not common for most organisms, the stereospecificity (D or L) of each 
amino acid can contribute to erroneous discrimination. In response to this problem 
one D-Tyr-tRNATyr deacylase has been found to act upon D-aminoacyl-tRNAs in 
bacteria, yeast and more recently human cells (Soutourina et al., 2000; Soutourina 
et al., 1999; Zheng et al., 2009). 
Two commonly referred examples of misacylation are: 1) the selection of L-
valine instead of L-isoleucine by E. coli IleRS, which differ only by one methyl 
group and 2) the selection of L-threonine by ValRS, which has a hydroxyl group 
instead of a methyl group like L-valine (Fersht, 1977; Fersht and Kaethner, 1976). 
So far, a second catalytic site, necessary for the double sieve model, has not been 
described for all aaRSs. 
Also, regulated misacylation events are known, for instance, the transamidation 
pathway, which was described in bacteria and archaea. Here, GluRS is used 
instead of GlnRS to produce Gln-tRNAGln (Becker and Kern, 1998; Wilcox, 1969; 
Wilcox and Nirenber.M, 1968) and AspRS is used to produce Asn-tRNAAsn 
 
Figure 9 - Quality control steps during the formation of a non-cognate aminoacyl-tRNA. Adapted 
from Reynolds et al. (2010) 
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(Curnow et al., 1996). Some organisms can only use this pathway (Curnow et al., 
1997). Beside bacteria and archaea this pathway was also described for yeast 
mitochondria (Frechin et al., 2009) and other eukaryotes (Nabholz et al., 1997; 
Schon et al., 1988).  
Other examples using different pathways are the production of cysteine which 
requires the O-phosphoseryl-tRNA synthase (SepRS) to acylate tRNACys and the 
formation of selenocysteine, which starts with the attachment of serine to tRNASec 
by a SerRS. It is worth noting that these examples, together with codon 
reassignments, show the evolutionary relevance of genetic code ambiguity (Moura 
et al., 2009). 
 
 
 
3.2 Decoding errors 
 
Decoding errors can happen mainly due to missense and nonsense errors 
and less frequently due to processivity errors. aa-tRNA selection has to be fast to 
achieve the optimum translation rate, leaving the translation machinery only a 
short time interval to explore the full discrimination potential between cognate and 
near cognate aa-tRNAs. Acceptance of near cognate tRNAs is avoided because of 
kinetic discrimination mechanisms. In a healthy organism the acceptance of non 
cognate tRNAs is rare. Besides codon organization the reciprocal relationship 
between E- and A-sites also contributes to tRNA discrimination. An occupied E 
site induces a low affinity A site and vice versa. So, the accommodation of the 
ternary complex will trigger the release of the tRNA in the E site (Nierhaus, 2006). 
The referred kinetic mechanisms are (Cochella and Green, 2005; Hopfield, 1974): 
 
1. Kinetic proofreading: this strategy resembles the double-sieve editing 
mechanism but instead of two different selective steps, the same basic 
principle is repeated. The first selection step explores the ability of the ternary 
complex to hydrolyze GTP. This is an easy task for the cognate complex but 
problematic for near cognate complexes, as they will most likely dissociate. 
The second selection step scrutinizes binding differences between codon and 
anticodon, as the cognate tRNA will more easily accommodate. Non cognate 
aa-tRNAs are essentially excluded in the first step, while near cognate ones 
can pass this step with a frequency of approximately 1 in 30. 
2. Induced fit: during initial selection, the rate of GTPase activation is significantly 
higher for the cognate aa-tRNA. During proofreading the accommodation rate 
is also higher. Summarizing, this strategy counts on the ability of cognate 
molecules to induce conformational changes on the enzyme and/or substrate, 
resulting in downstream effects on catalysis. 
 
Missense substitutions are quite common errors, occurring approximately at 
a frequency of 4x10-4 per codon translated in prokaryotes (Parker, 1989). 
However, only 1 in 400 misincorporations completely inactivate the protein by 
affecting its folding, structure or function (Nierhaus, 2006). Such substitutions 
result from mischarging of tRNAs or codon-anticodon mismatches on the 
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ribosome. Their detection is difficult because the resulting protein has essentially 
the same size and composition as the native one. Also, missense substitutions, 
can lead to frameshifting, as described below. 
Suppression of stop codons, known as translational readthrough, is another 
decoding error.  The stop codon is misread either by a mutated tRNA or a near-
cognate tRNA, which pairs with at least two bases of the codon. Here, the quality 
control mechanisms fail, and competition between the elongation and the 
termination machineries occurs. Nucleotide sequences surrounding stop codons 
can influence the readthrough efficiency. These context sequences can be quite 
complex (e.g. pseudoknots) (reviewed by Beier and Grimm, 2001). It is worth 
noting that premature stop codons lack this context sequences. In eukaryotes the 
nonsense-mediated mRNA decay mechanism can detect these premature codons 
and degrade the mRNA to avoid translation. Mutations like those in the yeast 
genes encoding eRF1 (SUP45) and eRF3 (SUP35), lead to suppression of the 
three stop codons (UAA, UAG, UGA) (Serio and Lindquist, 1999). 
Processivity errors can be widely defined as those causing the release of 
the nascent polypeptide chain prior to its completion. The resulting truncated 
peptide can be toxic to the cell and will probably have an energetic cost, especially 
if highly expressed. 
Frameshifts, which can be considered as processivity errors, are rare 
events (estimated error frequency of 3x10-5) that imply the alteration of the reading 
frame forward (+) or backwards (-) by one or more nucleotides. The most probable 
consequence is the production of truncated proteins due to early emergence of 
nonsense codons. For instance, tRNA slippage can happen if in the coding 
sequence the nucleotides before or after the target triplet are the same as the first 
and third of the latter, respectively. More rarely (10-15) the ribosome carrying a 
peptidyl-tRNA can slide along the sequence (Nierhaus, 2006). Further, the 
occupation of the E-site of the ribosome is also of great importance, because an 
empty one augments the probability of +1 frameshifts by 25% (Marquez et al., 
2004). Although not common, there are specific cases where frameshifts can be 
programmed like in viral genes, and in a single case in E. coli (Craigen et al., 
1985). A programmed frameshifting error has an efficiency of nearly 100%. Under 
these circumstances the mechanism controlling frameshifting seems to be 
switched off. In eukaryotes, programmed frameshifting has been observed as well 
(Manktelow et al., 2005; Weiss-Brummer et al., 1987; Wills et al., 2006). 
Nonsense errors that arise during replication or transcription can originate 
frameshifts and ribosome drop-off during translation. Other types of premature 
termination, which are not due to the presence of stop codons are thought to 
happen in two different ways: 1) the growing peptide could be released from the 
ribosome, followed by hydrolysis of the bond attaching it to the peptidyl-tRNA, or 
2) a release factor could misread a sense codon. It is hard to distinguish them 
experimentally and both are difficult to distinguish from frameshifts and ribosome 
pauses. In vivo, drop-off of peptidyl-tRNA from the ribosome seems to happen at 
frequencies between 3x10-3 and 10-4 per elongation event (Parker, 1989). 
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4. Translation Stress-induced Mutagenesis 
 
The great amount of possible mistranslation errors arising in cells activates 
intrinsic mechanisms, as described above. However, to cope with different types of 
stress and/or accumulation of errors, cells may be forced to evolve faster, in order 
to survive. Usually, a certain accumulation level of aberrant proteins results in a 
decrease in fitness, culminating in cell death. However, below this limit, cells can 
present a statistical population of proteins, consisting of a minor part of mutant 
proteins together with a major part of wild-type proteins. The mutant proteome 
fraction is expected to include unfolded proteins but also unstable proteins which 
can misfold and form toxic aggregates. The subsequent overloading of protein 
control systems might result in the activation of stress responses and alteration of 
gene expression. Nonetheless, this minor proteome grants genetic and phenotypic 
diversity and if phenotypic advantage arises, fixation of mutation may happen 
(Moura et al., 2009). 
If error-prone polymerases and defective DNA repair enzymes are 
produced they might originate hypermutagenic clones possibly exhibiting high 
adaptation potential (Moura et al., 2009). Recently, a hypermutagenesis 
phenotype associated with codon ambiguity was discovered in E. coli (Michaels et 
al., 1990) and named translation stress-induced mutagenesis (TSM). TSM has 
similarities with the SOS response (reviewed in Humayun, 1998), the best studied 
inducible mutagenic pathway in bacteria, as it also requires recABC and ruvAC 
(Ren et al., 2000). It is associated to two mutator loci named mutA and mutC 
which exhibit similar phenotypes. Compared to the wild-type strain they presented 
a transversion increase, namely the AT TA and GC TA changes, followed 
by the less frequent AT CG. These two mutators were found to encode glycine 
tRNAs, which mutations affected the anticodon (Slupska et al., 1996). The mutA 
allele consists of a tandem set of three identical tRNA genes (glyV), while mutC 
contains four copies of also identical tRNAs (glyW). Both alleles code tRNAs that 
misread the 5‟-GAU/C aspartic acid codon as glycine (5‟-GGU/C). In each case, 
only one copy is affected and so the existence of a statistical tRNA population, 
resulting in a low level of mistranslation was proposed. After comparison with 
mutD mutations, it was suggested that the low mistranslation level might be due to 
the action of an error-prone polymerase. The mutD/dnaQ gene mutations are 
implicated in the impairment of polymerase III (pol III) editing function, particularly 
the ε subunit, and implicate also the loss of an aspartic acid. DNA pol III was later 
established to be error-prone (Al Mamun et al., 2002; Dorazi, 2002). However, the 
exact changes of pol III are unknown. 
A mutator phenotype was also observed when cells were exposed to 
streptomycin, a translation inhibitor (Ren et al., 1999). Later on, using this same 
stressor, it was proven that mistranslation in general could induce TSM (Balashov 
and Humayun, 2002), possibly through enhanced protein misfolding and turnover, 
and culminating in the expression of an error-prone DNA polymerase (Dorazi et 
al., 2002). 
Finally, there is evidence in the literature supporting the appearance of 
other mutator phenotypes due to translational stress (Connolly and Winkler, 1989; 
Connolly and Winkler, 1991). 
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5. Antifungal drug resistance in fungi 
 
 
Microorganisms‟ resistance to drugs is a growing problem nowadays mainly 
as a consequence of treatment failures. In the present thesis we focused on 
antifungal drug resistance, in particular resistance to azoles, using S. cerevisiae as 
a model system. To date, most of the available information on this topic concerns 
the genus Candida and the antifungal fluconazole. Besides these two, other 
genera will only be mentioned briefly. 
In the mid-80‟s a significant amount of reports on antifungal drug resistance 
emerged. These concerned mainly resistant clinical isolates of Candida albicans, 
that were attributed to prolonged treatment with miconazole and ketoconazole 
(Sanglard et al., 1998). Nowadays about 200 yeast species are associated with 
humans, which are either commensals or pathogens. Actually, fatal invasive fungal 
infections are mostly caused by the commensals Candida, Aspergillus and 
Cryptococcus, which are opportunistic fungi. The costs associated with treatment 
of fungal infections are considerably high, even for the most common infections 
such as candidiasis. Patients‟ survival (specially for immunocompromised patients) 
is often time dependent and usually a correct diagnosis needs more than the 
available time. Therefore, patients are not always treated with the right antifungal 
from the beginning, thus favoring resistance increment.  
Currently, four antifungal classes are mainly used for treatment: 
echinocandins, fluorinated pyrimidine analogs, polyenes and azoles. Besides 
these, there are two other less used antifungal classes, the allylamines and the 
morpholines. The effectiveness of each antifungal depends on the fungus, the 
dose, the exposure time and the mechanism of action. Two types of drug-induced 
stresses, the short- and the long-term stress, can contribute to the survival of 
fungi. 
Briefly, echinocandins are lipopeptide molecules that inhibit beta-glucan 
synthesis by impairing the enzyme complex beta-(1,3)-glucan synthase, located in 
the cell wall. The first echinocandin, anidulafungin, was discovered in 1974 and 
more than ten years later, caspofungin and its precursor micafungin were 
developed (Denning, 2003). 
Fluorinated pyrimidine analogs such as 5-fluorocytosine, inhibit DNA and 
RNA synthesis by mimicking the structure of pyrimidines. This compound enters 
the cell via a permease and is converted into 5-fluorouracil by a cytosine 
deaminase. 5-fluoroacil can then be converted into 5-fluorouridylic acid, which is 
incorporated in RNA after phosphorylation or into 5-fluorodeoxyuridine 
monophosphate which interferes in DNA synthesis by inhibiting the enzyme 
thymidylate synthase (Ghannoum and Rice, 1999). It is used frequently in 
combination with polyenes. 
Widely used, polyenes such as amphotericin B, bind to ergosterol, a 
component of the fungal plasma membrane and thereby cause the formation of 
membrane-spanning channels. These channels provoke leakage of ions with 
consequent loss of cell integrity. Resistance to polyenes seems to be related to 
low ergosterol content, probably due to defective ERG3 function like described for 
azoles (Cowen and Steinbach, 2008). 
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There are two strong reasons why azole drugs are the most commonly 
used antifungals nowadays: firstly because unlike other drugs such as 
amphotericin B (polyene), mammalian cells tolerate them quite well and secondly 
because azoles act against a wide spectrum of fungi. This class comprises two 
generations named imidazoles (first generation, e.g.: ketoconazole and 
miconazole) and triazoles (second generation, e.g.: fluconazole and itraconazole). 
The first generation comprises, among others, miconazole, used in the current 
study, and ketoconazole. The primary target of azoles, is the ergosterol 
biosynthesis, in particular the cytochrome P450 Erg11p or lanosterol-14α 
demethylase (CYP51) encoded by the Erg11 gene. Azoles mimic lanosterol and 
compete for enzyme binding. This step is rate-limiting in ergosterol biosynthesis 
(figure 10). Ergosterol is a key component of fungi plasma membranes, analogous 
to mammalian cholesterol. 
 
 
 
 
 
 
 
 
 
 
Figure 10 - Part of the ergosterol pathway. Squares indicate azoles‟ target enzyme and the gene 
encoding it. Adapted from Bammert and Fostel (2000). 
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5.1 Resistance Mechanisms 
 
Luckily, fungi do not generally spread their resistance determinants like 
bacteria, nor mate often. Also, resistant isolates in human patients have never 
been reported to pass to other hosts. Still, several resistance mechanisms are 
known and the combination of two or more can result in synergy, antagonism or 
addition (Anderson, 2005). 
Membrane or osmotic stresses are short-term consequences of azole 
exposure, as cells are more and more depleted in their fundamental membrane 
molecule ergosterol. Briefly, such stresses can be fought by activation of 
conserved signaling pathways like the mitogen-activated protein kinase (MAPK) 
and the cyclic AMP-protein kinase A pathway (reviewed in Roman et al., 2007). 
Further, the serine/threonine protein phosphatase calcineurin, has an 
opposite mechanism of action, and is known to play a role in membrane stress. Its 
inhibition in C. albicans turns azoles from fungistatic into fungicidal drugs. Acting in 
the same signaling pathway as calcineurin, heat shock protein 90 (Hsp90) was 
also shown to contribute to fluconazole resistance in S. cerevisiae and C. albicans 
(Cowen et al., 2006; Cowen and Lindquist, 2005). However, the precise 
mechanism behind azole tolerance remains to be discovered. 
In most fungi, azoles cause growth arrest by reducing the ergosterol content 
of membranes and by accumulating toxic ergosterol precursors (e.g. 14α-
methylergosta-8,24(28)-dien-3β,6α-diol). However, there are species for which 
some azoles are fungicidal (e.g. Arpergillus fumigatus) (Espinel-Ingroff, 2001; 
Manavathu et al., 1998; Manavathu et al., 2000). Resistance to azoles seems to 
be acquired due to multiple mechanisms. These are, among others, 
overexpression or point mutations (confirmed to reduce fluconazole binding) of 
ERG11, efflux via ATP-binding cassette (ABC) and major facilitator superfamily 
(MFS) transporters, tolerance to methylated sterols via mutation in ERG3, stress 
tolerance induction and aneuploidy (Cannon et al., 2009). 
 
 
 
 
Figure 11 – Azole resistance: Three main forms of resistance to azoles can result from the 
upregulation of ABC and MFS transporters that remove the drug from the cell, through the mutation 
or overexpression of Erg11, which minimizes the impact of the drug on the target, or alterations in 
ergosterol biosynthesis, such as the loss-of-function mutation of Erg3, which blocks the 
accumulation of a toxic sterol intermediate that is produced when Erg11 is inhibited by azoles 
(Cowen, 2008). 
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 A gain of fitness is often associated with the development of azole 
resistance and therefore resistant isolates may persist in the cell population after 
the cessation of azole therapy. Evolution of resistance strongly depends on the 
population size, as each propagule (any fungal structure capable of dissemination) 
represents an independent possibility of resistance acquisition (Anderson, 2005). 
Yet to be precisely determined, certain levels of overexpression of drug 
efflux pumps, present in the plasma membrane, could reduce azoles to non toxic 
levels (Cannon et al., 2009). Lately, great interest has turned to these efflux 
pumps, especially in order to understand how these pumps bind and transport 
substrates, and to determine their “regular” substrates. Therefore, they will be 
described in more detail below. 
 
 
5.2 ABC and MFS transporters 
 
ABC proteins are primary transporters that require ATP hydrolysis and can 
be found in every organism‟s plasma membrane. Their basic structure consists of 
two nucleotide binding domains (NBD) and two transmembrane domains (TMD), 
which are arranged accordingly to the type of ABC protein. In S. cerevisiae ABC 
proteins can be divided in three subfamilies: pleiotropic drug resistance (PDR), 
multidrug resistance2 (MDR) and multidrug resistance-associated protein (MRP). 
The PDR subfamily is most frequently associated to antifungal resistance, with S. 
cerevisiae‟s Pdr5p considered as an archetype.  
 
 
 
 
 
As S. cerevisiae cells contain numerous ABC genes, a new system 
(Decottignies et al., 1998) was developed in a mutant species, which allowed 
background reduction. Using this system it was demonstrated that the genes 
YOR1 and PDR5 share miconazole as common a substrate. A derived system 
overexpressing CaCdr1p3 showed increased itraconazole resistance (1,000-fold) 
(Lamping et al., 2007). 
                                                          
2
 The term Multidrug Resistance is also used as a broader concept, covering other subfamilies, 
such as PDR and MDRp. 
3
 CaCdr1p – “Ca” stands for Candida albicans, the “p” usually stands for protein. 
Figure 12 - Possible arrangement of an ABC transporter (Cannon et al., 2009) 
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Clinical isolates of C. albicans were found to have increased levels of CDR 
genes (Perea et al., 2001), known to confer resistance to multiple azoles. 
Disruption of CaCDR1 led to hyper susceptibility to azoles and deletion of both 
CaCDR1 and CaCDR2 provoked even higher susceptibility (Sanglard et al., 1996; 
Sanglard et al., 1997). CaCDR1 overexpression in S. cerevisiae was found to 
confer cross-resistance to different azoles, including fluconazole, itraconazole and 
ketoconazole (Sanglard et al., 1995). Regarding CDR proteins, there is evidence 
that CaCdr1p, 2p and 3p are involved in phospholipid transport, having some 
influence in membrane leaflets composition. Thus, it was suggested that 
overexpression can indirectly contribute to antifungal resistance (e.g. effects on 
membrane function or membrane protein activity). Further, C. glabrata azole 
resistance is also associated with PDR ABC pumps (CgCdr1p and CgCdr2p). 
C. dubliniensis is another organism for which the genes CdCDR1 and 
CdMDR1 (MFS transporter) have been implicated in azole resistance. Contrary to 
C. albicans that preferentially uses CaCDR1 for drug efflux, CdMDR1 is directly 
linked to fluconazole resistance. CdCDR1, is not as commonly used, although it 
has been found to efflux ketoconazole and itraconazole and its deletion showed 
increased susceptibility to both azoles (for more detailed information see Sullivan 
et al., 2004). 
 
MFS pumps belong to protein superfamilies, that are widespread across 
phylogenetic domains. Their expression reveals a much weaker association with 
azole resistance than ABC transporters. They are secondary transporters, 
containing only TMDs that require a proton gradient and can be divided in two 
subfamilies regarding the number of transmembrane spans (TMS): DAH1 (12 
TMS) and DHA2 (14 TMS). 
 
 
 
 
 
 
 
 
The first MFS gene characterized was C. albicans’ CaMDR1. Later, the 
same gene was identified in fluconazole resistant mutants (Albertson et al., 1996) 
and clinical isolates of C. albicans (Perea et al., 2001; White, 1997). The same 
clinical isolates also showed increased levels of the ERG11 gene (White, 1997) as 
Figure 13 - Arrangement of a MFS transporter in C. albicans ans A. fumigatus. (Cannon et al., 
2009) 
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well as increased resistance to itraconazole, voriconazole, and posaconazole 
(Perea et al., 2001) Overexpression of CaMDR1 in S. cerevisiae conferred, I 
addition to fluconazole resistance, ressitance to ketoconazole (Lamping et al., 
2007), while only very high levels of overexpression led to fluconazole resistance 
in clinical C. albicans isolates (Hiller et al., 2006). Additionally, CaMDR1 confers 
resistance to other drugs (e.g. cerulenin and brefeldin A). 
Both types of efflux pumps are related to transcriptional factors that act as 
regulators. While exposed to antifungals, these can be subjected to gain-of-
function (point) mutations. Elements acting upon the PDR ABC subfamily of S. 
cerevisiae are among the best studied. Gain-of-function mutations have been 
identified in the genes of two transcription factors, ScPdr1p and ScPdr3p (Carvajal 
et al., 1997; Nourani et al., 1997). ScPdr1p is required to induce compensatory 
upregulation of efflux pumps if individual efflux pump genes are deleted (e.g. 
ScPDR5) (Kolaczkowska et al., 2008). 
Also, aneuploidy might play a role in azole resistance. A duplicated arm of 
the chromosome 5 of C. albicans clinical isolates was discovered to contain 
duplicates of the transcription factor gene CaTAC1, which regulates CaCDR1 and 
CaCDR2 (Selmecki et al., 2006). Transcriptional control mechanisms of the genus 
Candida, seem to be similar to those of S. cerevisiae. Finally, one other gene, 
CAP1, similar to S. cerevisiae‟s YAP1, was expressed in the latter and it was 
shown that it could activate the transcription of FLR1, which has functional 
similarity to the C. albicans MDR1 gene (Alarco et al., 1997). 
Solutions to efflux-mediated resistance are currently under investigation. 
Proposed solutions so far comprise 1) the use of antifungals that are not 
substrates of efflux pumps, 2) the development of systems that prevent efflux, 3) 
removal of the energy required by these pumps to function, and 4) attempt to shift 
the balance between antifungal uptake and efflux. Studies in S. cerevisiae have 
been carried out to identify pump inhibitors, as these possibly chemosensitize the 
cells to the antifungals (Cannon et al., 2009). Besides solving efflux-mediated 
resistance, other approaches under discussion, such as the development of 
stronger azole molecules and the discovery of new antifungal classes. Still, 
resistance will not disappear and more strains will evolve resistance more rapidly 
than expected. Research and drug use have to be directed in a way that channel 
resistance to a less harmful direction. The first attempt to channeling, currently in 
use, is combination therapy (two different antifungal drugs used simultaneously or 
in succession). Also, the development of new research tools (e.g. microarrays) can 
increase the knowledge available so far, providing more rapidly the information 
needed to find innovative solutions. 
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Materials and Methods 
 
1. Strains and growth conditions 
 
Mistranslating strains used in this work were constructed previously in our 
laboratory and are based on the S. cerevisiae BY4743 (MATa/αhis3Δ1/his3Δ1, 
leu2Δ0/leu2Δ0, LYS2/lys2Δ0, met15Δ0/MET15, ura3Δ0/ura3Δ0) strain. The 
control strain used has a single-copy plasmid, pRS315, while the mistranslating 
strains carry the same plasmid with a mutated tRNAUGA
Ser inserted between the 
BamHI and SalI restriction sites. The tRNAUGA
Ser anticodon was mutated by site-
directed mutagenesis, resulting in several other anticodons (Table 1) (Mateus, 
2011; Paulo, J. unpublished). Unlike the case of most aaRS, the SerRS 
recognition mechanism does not depend on the anticodons sequence, so 
acylation is not blocked. 
 
 
 
 
Table 1 – List of plasmids carried by strains used in this work. 
plasmid ID Description 
pUA262 pRS315 with Ser-tRNACAG
Leu 
pUA263 pRS315 with Ser-tRNAGUA
Tyr 
pUA265 pRS315 with Ser-tRNACGU
Thr 
pUA266 pRS315 with Ser-tRNACAC
Val 
pUA268 pRS315 with Ser-tRNAUGC
Ala 
pUA269 pRS315 with Ser-tRNAUCC
Gly 
pUA809 pRS315 with Ser-tRNACAU
Met 
pUA810 pRS315 with Ser-tRNAAGG
Pro 
Figure 14 - Single copy plasmid used for the expression of C. albicans tRNAUGA
Ser
 in S. 
cerevisiae BY4743. The UGA serine anticodon was mutated by site-directed mutagenesis to 
several other anticodons (see table 1) 
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All strains were grown at 30oC in minimal medium without leucine (MM-Leu) 
(0.67% yeast nitrogen base w/o amino acids, 0.2% amino acid drop out mix w/o 
leucine, 2% agar, 2% glucose (all from Formedium)). 
Stressor agents were added to the medium when required. Miconazole, 
itraconazole, amphotericin and cycloheximide (all from Sigma) were dissolved in 
DMSO (Sigma). Geneticin (Formedium) and caspofungin (Merck) were dissolved 
in Milli-Q water. 
 
 
2. Growth Curves 
 
Cell cultures of mistranslating strains and the control were grown at 30oC until 
they reached a late stationary phase and re-inoculated into 10mL of selective 
media with a starting OD595 of 0.100. At various time points aliquots of the cultures 
were harvested and OD595 was measured. The growth rates of each mistranslating 
strain were calculated relative to the control by using exponential phase values. 
Growth rates were compared with a one-way ANOVA coupled with Dunnett‟s 
multiple comparison test, with a 95% CI relative to pRS315, using GraphPad 
Prism software (GraphPad, Inc.). 
 
 
3. Antifungal susceptibility 
 
In vitro susceptibility was determined according to the guidelines of the 
EUCAST4 method for the determination of broth dilution minimum inhibitory 
concentrations (MICs) of antifungal agents (Rodriguez-Tudela et al., 2008). Briefly, 
for the inoculum, strains were grown on MM plates. 3 to 5 colonies were 
resuspended in PBS 1x and diluted to an OD530 of 0.15. Sterile 96-well plates 
containing a two-fold dilution series with twice the final concentrations of 
miconazole or fluconazole were inoculated with 100μL of cell suspension (3-
4replicas) or 100μL of PBS 1x (negative control). The final concentration of the 
antifungal ranged from 0.125 to 64mg/L. After 24h and 48h of incubation at 30ºC, 
the most suitable MIC values were determined (OD595). 
For all other antifungal susceptibility tests, the Etest® assay for MIC 
determination was utilized according to manufacturer‟s instructions (Biomerieux). 
All strains were tested for amphotericin B, caspofungin, itraconazole and 
flucytosine (except for proline- and methionine-to-serine strains). Therefore cell 
suspensions were grown in liquid MM-Leu medium until exponential phase and 
diluted to an optical density of 0.05. 150μL of cell suspension was inoculated onto 
selective agar plates and spread evenly with glass beads. Plates were incubated 
at 30oC. MIC endpoints were determined after 24h, 48h and 72h of incubation. A 
minimum of three independent tests was performed. 
 
 
 
 
                                                          
4
 European Committee on Antimicrobial Susceptibility Testing 
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4. Evolution of antifungal drug resistance 
 
Cells grown until exponential phase were inoculated into 15mL Falcon tubes 
containing liquid selective media and a miconazole concentration of 0.5μg/mL. 
Once a cell suspension reached the exponential phase it was changed to two new 
Falcon tubes, one containing twice the last used concentration of miconazole and 
the other containing the last used concentration as a backup. The experiment was 
carried on until the cells stopped growing. 
 
 
5. Development of translational-caused stress along with generation 
increment 
 
Cells were inoculated into 100mL Erlenmeyer flasks containing 20mL of MM-
Leu and ampicillin (100μg/mL, Sigma). As cultures reached the stationary phase 
they were changed to new media. MIC endpoints for the antifungals caspofungin 
and amphotericin were determined at the end of the experiment using the Etest® 
assay. 
 
 
6. Phenomics of mistranslating strains 
 
This experiment was based on the methods described by Homann (2009) and 
Kvitek (2008). BY4743 mistranslating strains were grown until exponential phase 
and 1x107 cells were collected and ressuspended in 1mL of PBS 1x. From this 
initial dilution, a series of 5 dilutions were made and transferred to 96-well plates. 
Six ten-fold serial dilutions were plated in MM-Leu agar plates supplemented with 
the following stressors: 
 
stress compound concentration (μg/mL) 
amphotericin B 0,5 
caspofungin 0,05 
itraconazole 0,25 
miconazole 0,05 
cycloheximide 0,06 
geneticin 75 
 
Cell suspensions were inoculated using a Sciclone liquid handling workstation 
and plates were incubated at 30oC. After 3 and 4 days photos were taken 
(Quantity One® software, Biorad) and areas of colonies were measured using 
Image J software (Abramoff, 2004). Due to the half time of antifungals, only data 
obtained at day 3 were considered for further analysis. Day 4 measurements were 
used in the case of the xenobiotic cycloheximide, as colonies sizes were too small 
to score after 3 days. The growth rates of each strain were calculated by dividing 
the average area of the triplicates of each strain exposed to the stressor by the 
average area of the triplicates of each strain grown in MM-Leu only. This ratio was 
calculated for all measurable dilutions. Statistics were made using GraphPad 
Prism software (GraphPad, Inc.). 
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7. Microarray analysis 
Images of the microarray hybridizations were previously acquired using the 
Agilent G2565AA microarray scanner (Agilent). Fluorescence intensities were 
quantified with Quantarray v3.0 software (PerkinElmer). Using R2.2.1 limma 
software (Smyth and Speed, 2003) and BRB-ArrayTools v3.4.0 (developed by Dr. 
Richard Simon and BRB-ArrayTools Development Team), log2 intensity ratios 
were median normalized, to correct for differences in genomic labeling efficiency 
between samples. One-class (to compare each mistranslating strain with the 
control) and multiclass (for comparison between mistranslating strains) 
Significance Analysis for Microarrays (SAM), with a false discovery rate (FDR) 
<0.001, were performed using MultiExperiment Viewer (MeV) 4.7.4 software 
(Saeed et al., 2003). Individual hybridizations of two clones with two dye-swaps 
were used as the input data for each strain. 
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Results 
 
 
1. Growth curves 
 
Growth curves were performed in order to understand how strains are affected 
by the toxicity caused by the introduction of the mutated tRNAs. Apart from the 
strain misincorporating serine at alanine codons, the results revealed that the 
growth rate of the mistranslating strains is slightly affected even though there were 
no significant differences in growth rate.  Misincorporation of serine at glycine and 
leucine codons led to lowest growth rates. 
 
 
 
Figure 15 – Growth curves (A) and specific growth rates (B) of yeast cells transformed with 
pRS315 only (control) and with pRS315 carrying the mistranslating serine tRNAs. Data represent 
the mean ± SD of duplicates of three independent experiments. 
 
 
 
2. Evolution of the mistranslating strains 
 
2.1. Antifungal susceptibility – broth dilution test 
 
A preliminary antifungal susceptibility test using the broth dilution method was 
performed with fluconazole (FLZ) to verify if this antifungal was suitable for an 
evolution experiment. As expected, the control strain BY4743 transformed with 
pRS315 tolerates the same concentration of FLZ as the wild-type (WT) BY4743. 
The mistranslating strains all showed the same inhibitory concentration (16mg/L). 
According to NCCLS guidelines, a MIC<16mg/L is considered as susceptible and 
a MIC>64mg/L is regarded as resistant to FLZ (NCCLS, 2002). Thus, this azole in 
particular is well tolerated by many fungal strains. For instance, according to 
EUCAST data, a small part of Candida strains tested grows up to 256 mg/L of 
FLZ5. Although our mistranslating strains fit in the NCCLS dose dependent 
                                                          
5
 http://www.eucast.org/mic_distributions/ 
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category, they tolerate relatively high concentrations of FLZ. Thus, this antifungal 
was discarded as a potential drug for an evolution experiment. 
 
 
 
 
 
 
 
Hence, a further commonly used antifungal, the imidazole miconazole, was 
tested and two more mutant strains were included which misincorporate serine at 
tyrosine and alanine codons. It was very effective against our strains. All of them 
were inhibited at a concentration of 0.5mg/L at 24h. For its high inhibition ability for 
most of the tested strains miconazole was chosen as a good candidate for an 
evolution experiment. 
 
 
 
 
 
 
 
 
 
Figure 17 - 24h MIC90 for miconazole determined by broth microdilution (EUCAST methodology). 
 
 
Figure 16 - 24h MIC90 for fluconazole determined by broth microdilution (EUCAST methodology). 
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2.2. Evolution of antifungal drug resistance 
 
As mentioned before, the S. cerevisiae strains used in this work have an 
increased frequency of misincorporation. Ongoing work in our laboratory led to the 
assumption that codon mistranslation, due to codon ambiguity, accelerates 
antifungal drug resistance in C. albicans. Here, we tried to force S. cerevisiae to 
evolve azole resistance, by exposing the strains to increasing concentrations of 
miconazole. All strains stopped growing at concentrations higher than 8mg/mL but 
they reached this concentration limit at different time points. 
 
 
 
Figure 18 – Evolution of the mistranslating S. cerevisiae BY4743 strains exposed to increasing 
concentrations of miconazole. 
 
 
 
 
 
 
 
Figure 19 - Strain misincorporating serine at alanine codons showing irregular intracellular 
structures, in 8μg/mL of MCZ (63x optical magnification). This picture is illustrative for all strains. 
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3. Antifungal susceptibility – Etest® assay 
 
We tested eight mistranslating strains plus the control for four different classes 
of antifungals (caspofungin, amphotericin B, itraconazole and flucytosine). The 
manufacturer‟s interpretation guide for C. albicans MIC endpoints was used as 
there are no indications available for S. cerevisiae. 
Caspofungin (CS) seemed to be a quite effective antifungal as none of the 
tested strains grew in concentrations higher than 0.25μg/mL. Amphotericin B (AP) 
inhibited the strains to a maximum concentration of 1.5μg/mL. In both tests the 
strains misincorporating serine at leucine and valine codons showed the weakest 
performance. The strain misincorporating serine at tyrosine codons had a similar 
performance to the control, when exposed to AP. All the other mistranslating 
strains were in general more resistant to AP and more susceptible to CS than the 
control. 
 
 
 
 
 
 
 
 
 
Figure 20 - Caspofungin 48h MIC80 endpoints of the mistranslating strains and control, 
determined with the Etest assay. Strains misincorporating serine at leucine and valine codons did 
not grow sufficiently to determine the MICs at 48h and therefore 72h MICs are presented. 
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Itraconazole Etests were performed only once and not repeated as strains have 
shown high resistance (figure 22). It is important to refer that ITZ Etest strips range 
from 0.002 to 32μg/mL. Performance differences between the strains were still 
determined: the control strain and the strains misincorporating serine at threonine 
and glycine codons were inhibited at 16μg/mL, while the strains misincorporating 
serine at methionine, proline and valine codons were inhibited at 24μg/mL; the 
strains misincorporating serine at leucine and alanine codons had the best 
performance (32μg/mL) and the one misincorporating at tyrosine codons has the 
weakest (12μg/mL) (figures 22 and 23).  
The strains showed no inhibition towards flucytosine (FC) exposure except for 
the one misincorporating serine at leucine codons (fig 24). For this reason FC 
Etests were not repeated. 
 
 
 
Figure 22 - Itraconazole 48h MIC80 endpoints of the mistranslating strains and control, determined 
with the Etest assay 
. 
 
Figure 21 – Amphotericin B 48h MIC100 endpoints of the mistranslating strains and control, 
determined with the Etest assay. Strains misincorporating serine at leucine and valine codons did 
not grow sufficiently to determine the MICs at 48h and therefore 72h MICs are presented. 
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4. Development of translational-caused stress along with generation 
increment 
Here we intended to understand if the accumulation of errors due to induced 
codon ambiguity could be per se a major stressor to change the antifungal 
resistance of the tested strains. There were small differences regarding antifungal 
resistance between strains in generation “zero” and after 230 generations for the 
two antifungals tested (figure 25). Cell morphology did not seem to be altered 
(figure 26). 
 
Figure 23 –Examples of the itraconazole Etest assay presented in figure 18: control (A) and the 
strains misincorporating serine at alanine and glycine codons (B and C respectively). 
 
Figure 24 – Examples of 5-flucytosine Etest assay: Control  strain (A) and strains misincorporating 
serine at leucine and alanine codons after 48h incubation period (B and C, respectively). 
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5. Phenomics of mistranslating yeasts 
 
Induced mistranslation is expected to trigger a stress response that may have 
more severe effects in the cells carrying the most toxic mutated tRNAs. 
Confirmation of its degenerative character in these strains was previously done in 
the laboratory. However, it was also shown that some of these strains have a 
selective advantage under certain environmental conditions (e.g. copper sulphate) 
(Mateus, 2011). To verify whether mistranslation induces a selective advantage 
towards exposure to different antifungals and translation inhibitors we performed a 
phenotypic screening. From the available set of antifungals, we could test two from 
the azole family (miconazole and itraconazole), one echinocandin (caspofungin) 
and one polyene (amphotericin). Additionally, geneticin and cycloheximide, two 
translation inhibitors, were tested (figure 27). 
Figure 26 – S. cerevisiae strains – control, strain misincorporating serine at proline codons and at 
methionine codons respectively - morphology after approximately 230 generations (63x optical 
magnification). These pictures are illustrative of what was visualized for all of the strains. 
 
Figure 25 – Comparison of 48h MICs of strains at the beginning of the experiment (t=0) and 
strains grown until the 230 generation approximately, determined by the Etest for caspofungin 
(MIC80) and amphotericin B (MIC100). 
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The results obtained show that mistranslating strains cope better the exposure 
to cycloheximide than the control strain. Cycloheximide is a powerful translation 
inhibitor and the growth rate of all strains was affected when compared to the 
growth in media without the stressor (figure 28). The strain misincorporating serine 
at methionine codons had the best relative growth rate (+64%), followed by strains 
misincorporating at proline and alanine codons (about +50%). 
Geneticin, another translation inhibitor, was less effective. It did not affect 
mistranslating strains‟ growth as much as cycloheximide (figure 28) but when 
compared to the control strain (figure 27), their performance decreased. 
Misincorporation of serine at leucine codons was the most disadvantageous (-
30%); at threonine codons growth was similar to the control (+1%); and the only 
advantageous strain was the one misincorporating serine at proline codons 
(+22%). 
Regarding caspofungin resistance the results revealed that the strain 
misincorporating serine at leucine codons did not grow at all, while the strain 
misincorporating serine at valine codons grew similarly to the control (only -8% of 
growth). The strains misincorporating serine at tyrosine (-33%) and threonine (-
27%) codons are the most affected, followed by the one misincorporating serine at 
glycine codons (-21%). 
The tested amphotericin concentration of 0.5μg/mL did not seem to highly 
affect cells‟ growth (figure 28). Therefore, 1 μg/mL of this compound was also 
tested during this experiment and none of the strains grew during the first three 
days. After 5 days colonies were still not suitable for ImageJ analysis. These 
results did only partly match the Etest assay results. 
The response to both azoles was quite different. Mistranslating cells tolerated 
itraconazole better than the control while miconazole seemed to affect them more. 
The strain misincorporating serine at alanine codons showed better growth than 
the control when exposed to both azoles, but it was quite obvious in the case of 
Figure 27 – Growth performance of yeast cells transformed with pRS315 containing the mutant 
tRNA
Ser
 under 6 stress conditions. Growth is represented as advantageous (red), disadvantageous 
(green) or neutral (black) compared to growth of the control strain pRS315. Grey squares 
represent eliminated values. 
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ITZ (+66%). The strain misincorporating serine at valine codons showed the 
second best performance (+44%). However, the leucine-to-serine strain presented 
half the growth rate (+20%) of the valine-to-serine one. There was also a 
difference between them in MCZ supplemented media but it was more obvious in 
the case of ITZ. 
Some strains have not grown measurable colonies beside for the initial 
dilution, which left us with a poor set of values and hence, increase erroneous 
interpretation. This concerned the strains misincorporating serine at glycine and 
threonine codons for the antifungal MCZ and serine at tyrosine and threonine 
codons for itraconazole. For the reasons mentioned these results were not taken 
into account. 
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Figure 28 – Relative growth of yeast cells transformed with mutant tRNA
Ser
. Data represent the 
mean ± SD of triplicates of three independently grown replicates (***p<0,0001. One-way ANOVA 
coupled with Dunnett‟s multiple comparison post test, with a 95% CI relative to pRS315). 
  
  
  
36 
 
6. Microarrays 
 
As an attempt to explain the results of the phenomics study in molecular 
terms, microarray data obtained previously in our laboratory were analyzed. This 
analysis was meant to find a possible predisposition of the mistranslating strains 
regarding resistance to antifungals and translation inhibitors. Unfortunately, no 
microarray data was available for the strains misincorporating serine at proline and 
methionine codons. 
 
 
Table 2 – Total number of significant differentially expressed genes by the mistranslating strains 
compared to the control strain, determined by one-class SAM analysis (FDR≤0.0001). 
strain down-regulated up-regulated total 
Ser-tRNACAG
Leu 18 92 110 
Ser-tRNAGUA
Tyr 29 187 216 
Ser-tRNACGU
Thr 3 25 28 
Ser-tRNACAC
Val 32 136 168 
Ser-tRNAUGC
Ala 106 34 140 
Ser-tRNAUCC
Gly 4 110 114 
 
 
 
Table 3 - Number of genes related to amino acid biosynthesis (previously described by Singh et al., 
1979) that were significantly differentially expressed by the mistranslating strains compared to the 
control strain, determined by one-class SAM analysis (FDR≤0.0001). 
strain down-regulated up-regulated amino acids 
Ser-tRNACAG
Leu 0 10 Glu, Lys, Met 
Ser-tRNAGUA
Tyr 3 17 Glu, Lys, Met, Ser, Gly 
Ser-tRNACGU
Thr 0 2 Lys 
Ser-tRNACAC
Val 0 11 Glu, Lys, Met 
Ser-tRNAUGC
Ala 3 2 Glu, Lys, Ser, Gly 
Ser-tRNAUCC
Gly 0 4 Glu, Lys, Ser 
 
 
 
Our SAM (Significance Analysis for Microarrays) analysis revealed that, 
when compared to the control, the mistranslating strains up-/down-regulate more 
genes that have been previously connected to amphotericin B response (55 
genes) than to any other antifungal used in our tests. Further 25 genes related to 
azole response and 36 genes related to CS response were differentially expressed 
by the mistranslating strains (figure 29). 
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Figure 29 – One-class SAM analysis – selected genes previously related to S. cerevisiae‟s 
response towards amphotericin B (left) and caspofungin (right). 
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Figure 30 – One-class SAM analysis – genes previously related to S. cerevisiae‟s response 
towards azoles 
 
The multiclass Significance Analysis for Microarrays (SAM) revealed a total 
of 182 differentially expressed genes. A list of these genes is given in the annex. 
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Discussion 
  
1. Antifungal susceptibility – Etest® assay 
 
 The mistranslating strains showed MIC endpoints (80% inhibition) that did 
not surpass 0.3μg/mL of caspofungin (CS), revealing that this antifungal is very 
effective. Mistranslation did not seem to alter the strains susceptibility as the 
mutant strains showed MICs similar to the control. Echinocandins were previously 
shown to be very effective, even fungicidal, against most common Candida spp, 
presenting lower MICs than those described for amphotericin B (AP). On the other 
hand, CS was shown to be mainly fungistatic against Aspergillus spp. (Denning, 
2003). A previous study on clinical isolates of S. cerevisiae using the Etest assay 
revealed a 50% inhibition in the range of 0.25 to 0.5μg/mL of CS (48h) 
(Chryssanthou and Cuenca-Estrella, 2002). Our laboratory strains do not greatly 
differ from these values. 
 The MIC endpoints (100% inhibition) obtained for the AP Etest assay 
showed more interesting results. A slight advantage towards AP exposure was 
observed for the strains misincorporating serine at glycine, methionine and 
threonine codons. Threonine is chemically and structurally similar to serine while 
glycine is a special amino acid, as it can fit in hydrophobic and hydrophilic parts of 
a protein. The introduction of serine into a hydrophobic part of a protein could have 
severe consequences, such as, e.g., loss of function due to incorrect folding. In 
principle, a decrease in antifungal resistance would be expected, as the cell fitness 
also decreases (Mateus, 2011). Also, the result obtained for the strain 
mistranslating methionine was surprising. A priori a methionine substitution by 
serine should have severe consequences due to their chemical and structural 
differences. Methionine is hydrophobic and contains a sulphur atom, which confers 
stability to the protein and helps it to fold due its ability to form disulfide bonds. 
Other studies using the NCCLS or the EUCAST methodologies showed MIC 
endpoints (90% inhibition) in the range of 0.5 to 1μg/mL (Lass-Florl et al., 2008; 
Munoz et al., 2005; Pfaller et al., 1997; Swine et al., 2004; Thompson et al., 2005). 
 Moreover, it was also interesting to see that three of the mistranslating 
strains had AP MIC endpoints similar to the control. These were the strains 
mistranslating serine at alanine, proline and tyrosine codons. Again, if the 
chemical and structural differences of serine and these three amino acids were 
solely taken into account, a decrease in their performance would be expected. 
Further investigation should be done in order to clarify such results. 
 The MIC endpoints of the strains misincorporating serine at leucine and 
valine codons were assessed 24h later (72h), for both CS and AP, as the strains 
were not sufficiently grown for an accurate determination after 48h. Both strains 
showed lower MIC endpoints than the other mistranslating strains and the control. 
Such results might be due to the fact that the strains seem to be dealing with a 
growth delay, and are less fit to cope with the antifungals. Furthermore, it was 
previously shown in our laboratory that mistranslation, in different ways, affects 
these two strains more than the other strains studied here (Mateus, 2011). 
 The MIC endpoints (80% inhibition) determined for itraconazole (ITZ) were 
very high (12-32μg/mL) for the mistranslating strains and the control strain (figure 
18). As mentioned before, these strips range from 0.002 to 32μg/mL. Because of 
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this range, the resulting ellipses presented similar small areas (figure 19). The 
Etest guidelines include interpretive criteria for the various antifungals tested. 
However, it concerns uniquely Candida strains. For instance, for ITZ a strain is 
considered susceptible dose dependent (SDD) if the MIC is in the range of 0.25 to 
0.5 μg/mL. According to NCCLS official breakpoints, SDD strains present MIC50 in 
the range of 0.25 to 0.5μg/mL. Above and below these values, strains are 
considered as being resistant and susceptible, respectively. MIC endpoints such 
as the ones obtained were not in accordance with most published MICs (50 to 
90% inhibition, determined with NCCLS and EUCAST methodologies) obtained for 
clinical isolates of S. cerevisiae (Espinel-Ingroff, 1998; Lass-Florl et al., 2008; 
Munoz et al, 2005; Permán J., 2006; Pfaller et al., 1997; Swine et al., 2004; Zerva 
et al., 1996). It is important to stress that an agar diffusion test was used in this 
work while the NCCLS and EUCAST methodologies use liquid media. Cuenca-
Estrella et al. (2005) compared the EUCAST methodology with several 
commercial systems using Candida isolates and an overall 90% agreement was 
observed for Etest (amphotericin B, flucytosine and several azoles). 
 Regarding 5-flucytosine (FC) Etest results we observed that all of the 
strains exhibited resistance but for leucine. MIC endpoints obtained previously for 
S. cerevisiae strains using different methods seem to be much lower (Berenguer 
et al., 1995; Espinel-Ingroff et al., 1991; Pfaller et al., 1995; Pfaller et al., 1997; 
Thompson et al., 2009). To our knowledge, there is at least one case in which a 
laboratory strain, the haploid BY4741, was shown to be resistant to FC, presenting 
a MIC95 of 100μg/mL (microdilution broth, 48h) (Markovich et al., 2004). BY4741 is 
a haploid strain that is very similar to the diploid strain, BY4743, used in this work. 
Both strains share the same deletions except for the gene LYS2 that is only 
deleted in the BY4743 strain. Resistance to 5-FC can be mediated by two basic 
mechanisms (Vermes et al., 2000): (i) certain mutations can result in a deficiency 
in the enzymes necessary for cellular transport and uptake of 5-FC or for its 
metabolism (i.e. cytosine permease (FCY2), uridine monophosphate 
pyrophosphorylase (FUR1) or cytosine deaminase (FCY1)); (ii) resistance may 
result from increased synthesis of pyrimidines, which compete with the fluorinated 
antimetabolites of 5-FC and thus diminish its antimycotic activity. The multiclass 
Significance Analysis for Microarrays (SAM) showed that FUI1 and URA1 genes 
are differentially expressed in mistranslating strains. The FUI1 gene codes for a 
high affinity uridine permease, localized to the plasma membrane and null mutants 
have showed increased resistance to FU (Jund and Lacroute, 1970). Up-
regulation of FUI1 in the strain misincoporating serine at alanine codons might 
contribute to the uptake of uridine and balance the ratio U/FU. The URA1 gene 
codes for a dihydroorotate dehydrogenase which catalyzes a key reaction in the 
superpathway of histidine, purine, and pyrimidine biosynthesis. This reaction takes 
place immediately before the branching of the pathway, which can prevent or 
increase the formation of uridine-triphosphate (UTP). The strain misincorporating 
serine at alanine, tyrosine and valine codons showed up-regulation of this gene. 
Curiously, a point mutation that replaced serine by leucine in C. dubliniensis was 
suggested to cause FC resistance, by disrupting the quaternary structure of the 
enzyme, distorting the active site (McManus et al., 2009). We verified that S. 
cerevisiae‟s FCY1 gene contains only one CUG codon (leucine), the FUR1 gene 
contains two CUG codons and FCY2 contains nine CUG codons. Thus there is the 
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possibility that one of these genes‟ products is affected. A previous study that 
tested a set of 39 yeast proteins of the SWISS-PROT database, has shown that 
leucine is the most abundant amino acid, appearing in these proteins with a 
frequency of almost 10%. Valine, for instance, appears with a frequency around 
6% only (Pratt et al., 2002). Microarray analysis of the mistranslating strains 
exposed to FC could shed light on this matter. Previous microarray studies using 
S. cerevisiae have already shown that FC triggers differential regulation of genes 
involved in several different functions (e.g. amino acid metabolism, cell cycle, 
protein degradation) (Agarwal et al., 2003). 
 
 
2. Evolution of antifungal drug resistance 
 
 The forced evolution experiment revealed that mistranslating strains were 
as resistant to the antifungal miconazole (MCZ) as the control was and no visible 
differences in cell aggregation were qualitatively observed using the microscope. 
Although the initially determined MICs were quite low and the experiment ended 
with a final concentration of 8μg/mL, it is known that laboratory strains such as BY 
can grow in 10μg/mL MCZ supplemented media and others reach similar 
concentrations (Francois et al., 2009; Parker et al., 2008; Portillo and Gancedo, 
1984; Thevissen et al., 2007). Azoles are mainly fungistatic, high MIC variations 
are expected when grown in different media and volume, presence or absence of 
oxygen and even when temporal independent experiences are performed 
(Agarwal et al., 2003; Sud and Feingold, 1981). As the final limiting MCZ 
concentration of our evolution experiment (8μg/mL) was similar to other published 
inhibitory concentrations for this specific antifungal in baker‟s yeasts we assumed 
that our mutant strains are as resistant to MCZ as wild type strains and 
mistranslation did not increase MCZ resistance in the course of the experiment. It 
was interesting to observe that the strains misincorporating serine at leucine and 
alanine codons needed more time to reach 8μg/mL, while the strains 
misincorporating at glycine and threonine codons reached the same concentration 
quicker. Such observation might be due to the fact that both alanine and leucine 
amino acids are non polar, while threonine is polar like serine and glycine is a 
special case, as it has no side chain. 
 The observations on the microscope at the final steps of this experiment 
showed structures that might be vacuoles. Vacuoles are common in every growth 
stage of a yeast cell but their morphology does not remain unchanged along the 
growth process. Azoles cause a decrease in cell wall integrity, by impairing 
ergosterol biosynthesis. As a consequence, ion leakage increases leading to 
osmotic stress, which in turn causes the formation of small, fragmented vacuoles. 
It has been suggested that such fragmentation may increase the efficiency of ion 
uptake by vacuolar transporters (higher contact area) (Li and Kane, 2009). Also, 
vacuoles play an important role in detoxification, thus the cells might try to 
sequester MCZ inside the vacuoles. 
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3. Development of translational-caused stress along with generation 
increment 
 
 This long term experiment was carried out for approximately 230 
generations in order to study the effects of mistranslation on the genome over 
time. It did not lead to neither growth nor cell morphology differences. Only slight 
differences in resistance to AP of the strain misincorporating serine at proline 
codons were observed. High resistance was not expected as cells are not under 
additional antifungal-caused stress. The main goal of this experiment is to do 
whole genome sequencing (WGS) to verify if induced mistranslation indeed 
augments DNA mutation rate over time. As mentioned before, mistranslation can 
affect DNA synthesis, repair and recombination proteins. At a certain point there is 
the possibility that cells produce a significant amount of mal-functioning (or 
unfolded) proteins. If a DNA polymerase subunit is affected (e.g. production of 
error-prone holoenzyme), like shown before in bacteria (Al Mamun et al., 2002), it 
could introduce more mutations in the DNA. The more DNA mutations, the higher 
the possibility of producing erroneous proteins, and the closer the cell gets to the 
death threshold. We had no evidence for an advantageous phenotype in the 
forced evolution experiment, although experiments using streptomycin in bacteria 
showed that mistranslation in general could induce TSM (Balashov and Humayun, 
2002). The WGS will allow us to screen for the expected higher level of point 
mutations and Indels spread across the genome.  Even though theoretically 
possible, it is worth noting that the introduction of a mutant tRNA such as glyVGlu 
and alaVGlu, immediately caused the emergence of a mutator phenotype in 
bacteria (Dorazi et al., 2002). Nevertheless we can predict some changes in DNA 
polymerases. For instance, the quantity of proline codons CCU and methionine 
codons AUG in some polymerases is: 
 The sliding clamp for DNA polymerase delta (POL30) has 7 proline codons 
of which 5 (CCU) can be recognized by the suppressor tRNAAGG
Ser and 5 
methionine codons (initiator excluded). 
 The subunit of DNA polymerase delta (gene POL31), which is involved in 
DNA replication and repair and is essential for cell viability, contains 28 
proline codons of which 7 (CCU) can be recognized by the suppressor 
tRNAAGG
Ser and 9 methionine codons. 
 A subunit of DNA polymerase delta (gene POL32) contains 21 proline 
codons of which 7 (CCU) can be recognized by the suppressor tRNAAGG
Ser 
and 7 methionine codons. 
 Thus,  there is the possibility that amino acid exchange can produce a fair 
amount of unstable DNA polymerases. If WGS confirms this theory, a logical step 
would be to study the other DNA polymerases involved only in DNA repair (e.g. 
zeta subunits). As it is known that mistranslation involves several different events, 
later on, it could be interesting to check RNA polymerases sequences too. 
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4. Phenomics study and microarray analysis 
 
In general, there was no visible pattern regarding the antifungal drug 
response of the mistranslating strains, nor seemed to be similarities for both 
translation inhibitors tested. Examples are leucine- and valine-to-serine strains, 
two of the most toxic codon changes, which were expected to have more similar 
responses to, for instance, itraconazole and caspofungin. Our laboratory showed 
recently by northern blot analysis and beta-galactosidase assays that the cell tries 
to shut down the expression of the mistranslating tRNAs and the most affected 
strains have been these two. Also, these showed higher percentages of cell death, 
and together with isoleucine-to-serine strain (not used in this work), were the only 
ones affected by aneuploidy. So, these two strains are always on the spotlight of 
most of the experiments already made in our lab (Mateus, 2011). It seems that the 
antifungal response is greatly affected by each specific type of mistranslation. 
  It was previously shown that CUG ambiguity in S. cerevisiae strains 
expressing the C. albicans ser-tRNACAG induced tolerance to oxidants, high 
osmolarity (Santos et al., 1999) and temperature shifts (Santos et al., 1996). Some 
of our mistranslating strains showed a growth advantage in antifungals. 
In the phenomics study all of the strains grew in agar plates supplemented 
with 0.5μg/mL of amphotericin B (AP) and reacted similarly to the control which 
was not greatly affected by this polyene. Curiously, the growth rate of the strains 
mistranslating serine at leucine and valine codons was similar to all others. 
It was surprising to observe that the strains misincorporating serine at 
proline and methionine codons were not highly affected by any of the drugs, 
regarding that both amino acids are hydrophobic and with complex side chains. 
On the contrary, in some situations they showed a growth advantage (e.g. ITZ 
Etest). Such observation is in agreement with the Etest results (see above). The 
study by Pratt and colleagues (2002) further confirmed that methionine and proline 
are amongst the least abundant amino acids. The fraction of mutant proteins 
produced may be lower in these two strains, and thus, may have less influence on 
the cells‟ fitness. Further investigation might add an explanation to our current 
knowledge. 
The microarray data, revealed that there were no differentially expressed 
genes related to antifungal targets such as those decoding the ergosterol pathway 
or ABC and MFS pumps (with two exceptions for the tyrosine-to-serine strain). 
However, we had the curiosity to use false discovery rates (FDRs) lower than 1% 
(instead of the considered FDR<0.0001) and noticed that when compared to the 
control strain (one-class SAM), valine-to-serine misincorporation showed down-
regulation of ERG1 and ERG3. Next to ERG11, ERG3 is probably the most 
important gene for azole resistance, as cells tend to introduce point mutations in 
order to stop the accumulation of toxic ergosterol intermediates (Cowen, 2008; 
Cowen and Steinbach, 2008). Thus, this could in part account for its better 
response towards ITZ and MCZ, when compared to leucine-to-serine strain‟s 
response and to the other strains in general. 
It was previously shown in our laboratory that mistranslating strains 
increase the level of ROS production mainly during the exponential phase and the 
most affected are those misincorporating serine at leucine, isoleucine (not used in 
this work) and valine codons (Mateus, 2011). An increased level of ROS was 
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shown to be characteristic of yeast cells exposed to MCZ and its forced reduction 
decreased MCZ action (Kobayashi et al., 2002). Such ROS levels might have 
reduced the growth rate of leucine- and valine-to-serine strains under MCZ 
treatment, even though (to our knowledge) a direct comparison of the effect of 
both azoles on the intracellular ROS level was not made yet. Still, a comparison 
between MCZ, CTZ and FLZ, showed that only the first one induces high levels of 
ROS in C. albicans, which can possibly be due to the combined inhibition of 
peroxidase and catalase observed (Francois et al., 2006). 
A curious observation was that the generally highly affected strain 
misincorporating serine at leucine codons did not seem to be highly affected by 
ITZ exposure. It grew similarly to the control strain pRS315 in both the phenomics 
test and the Etest assay. Further investigation could shed light on such startling 
observation. 
The strain misincorporating serine at tyrosine codons was one of the 
weakest strains under ITZ exposure and grew only in the initial dilution. This result 
is in accordance with the observed before for the ITZ Etest assay. However, it 
grew almost similarly to the control under MCZ exposure. Such structurally 
different amino acids are expected to provoke stronger consequences when 
exchanged. They are both polar and uncharged but tyrosine‟s side chain is longer 
and contains an aromatic ring. Besides structure, some tyrosine residues can be 
(de-) phosphorylated. Several cell components transmit signals via pathways 
involving tyrosyl phosphorylation of specific proteins. Such pathways influence 
survival or death and regulation of phosphorylation is critical for homeostasis (Neel 
and Tonks, 1997). Impediment of such important events by the insertion of a 
serine instead of tyrosine could, in principle, reduce the cells‟ fitness and their 
ability to deal with antifungals. Interestingly, the microarray analysis showed that 
this strain had the highest up-regulation of genes related to azole response. Singh 
and colleagues (Singh et al., 1979) showed that yeast cells with low ergosterol 
content accumulate a selective set of amino acids (lysine, glycine, glutamic acid, 
proline, methionine and serine) at a higher rate and level. Also, Thevissen and 
colleagues (2007) observed that the deletion of several tryptophan genes 
decreased MCZ resistance in yeast. Interestingly, our strain up regulates several 
genes related to amino acid biosynthesis, which could possibly indicate a 
predisposition to cope with azole exposure. In addition, it up regulates ATR1, 
which codes for a MFS pump, whose overexpression is known to confer 
aminotriazole resistance (Kanazawa et al., 1988) and SNQ2, which codes for an 
ABC pump of the PDR family, known to confer multidrug resistance (Ernst et al., 
2005). Curiously, the threonine-to-serine strain, which did not tolerate both azoles 
well, had a low number of up-regulated genes related to amino acid biosynthesis. 
Additionally, we verified that there was down-regulation of FRE1 gene, a ferric 
reductase, only in the tyrosine-to-serine strain (see annex). This gene was 
previously connected to ITZ resistance in S. cerevisiae (Barker et al., 2003). 
The strain misincorporating serine at glycine codons had, except for 
cycloheximide, a weaker performance than the control towards the compounds 
tested. Such observation was expected as these two amino acids differ structurally 
and chemically: glycine is the tiniest amino acid, without side-chain, while serine is 
polar and with a small side chain. This means that glycine has the unique ability to 
fit in small spaces of a folded protein and it can also be found in hydrophilic and 
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hydrophobic environments. Thus, the substitution of glycine with serine can lead to 
incorrect folding of proteins. 
Interestingly, the strain misincorporating serine at alanine codons copes 
better than the control with azoles. Alanine is the second tiniest amino acid but 
carries a non polar side chain, which makes this substitution harder for the cells to 
deal with, as serine is preferentially located at the outer side of the proteins. 
Another curious observation was that this strain presented the most down-
regulated genes, when compared to the control (table 2). Actually, its genes linked 
to AP resistance are mostly down-regulated. This down-regulation differs from 
published results for exposed yeast cells (Agarwal and colleagues (2003), which 
observed up-regulation of genes such as GPH1, HSP12, HSP26, PHO5, PIR3 and 
YOR2 after exposing S. cerevisiae strains to AP). However, the strain might 
change gene regulation accordingly if exposed to the antifungal. 
Regarding CS the leucine-to-serine strain had the weakest performance as 
it did not grow at all. Such result is startling and leads one to question the reason 
why beta-1,3-glucans are so important for this strain. Glycine-, leucine- and 
tyrosine-to-serine strains present the most up regulated genes previously related 
to CS response. From the microarray data, the up-regulated gene that immediately 
draws one‟s attention to it is GSC2, a catalytic subunit of the 1,3-beta-glucan 
synthase. The other catalytic subunit is GSC1, is not significantly differentially 
expressed. This is not surprising as they are thought to act as alternate subunits 
(Denning, 2003). These two proteins are controlled by Rho1p, which in turn is 
controlled by Tor2p, a TOR signaling pathway protein (Schmidt et al., 1997). In 
addition, Rho1p regulates Pkc1p, a MAPK pathway protein, which in turn seems to 
play a role in GSC1 expression (Gustin et al., 1998; Igual et al., 1996). GSC1 was 
previously shown to confer specific resistance to CS (Markovich et al., 2004). For 
their proximity, GCS2 may possibly play a direct role in CS resistance too. It would 
be interesting to see if our strains exposed to the antifungal would up-regulate 
both GSC2, FSK1 and RHO1 genes. 
 DDR2 is also up-regulated in the strains misincorporating serine at glycine, 
leucine and tyrosine codons. Although not many information is available about this 
gene it has been suggested a possible role in the response of cells to diverse 
environmental stresses. So far it is known that it is rapidly activated after heat 
shock and DNA damage (Kobayashi et al., 1996).  
 It was surprising to verify that the control strain was more affected by 
cycloheximide (CHX) than most of the mistranslating strains. The opposite was 
verified for geneticin (even if a higher concentration was used), leading us to 
conclude that it is a much weaker translation inhibitor in yeast. Both compounds 
act during the elongation step, but their chemical nature is distinct. Geneticin is an 
aminoglycoside antibiotic, that acts against prokaryotic and in much lower extent 
against eukaryotic cells. In prokaryotes it binds to the 16S ribosomal subunit and 
blocks translocation of the tRNA from the A-site to the P-site. In general, 
aminoglycoside antibiotics bind to regions of the prokaryotic ribosome that are not 
conserved in eukaryotes. Also, the fact that such drugs are positively charged, 
reduces their uptake by eukaryotic cells. Besides blocking translocation it was also 
suggested that aminoglycoside antibiotics decrease the proofreading ability of the 
ribosome, decreasing translation fidelity (reviewed by Hermann (2007)). CHX also 
binds to the ribosome and blocks eEF2-mediated translocation but the mechanistic 
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details of its action remain unclear. It was suggested that mutations in genes 
coding for ribosomal proteins, such as CYH2 and L41, might increase CHX 
resistance (Kaufer et al., 1983; Kawai et al., 1992). Our mistranslating strains 
might be more prepared to handle ribosome inhibition, as they are already coping 
with an increased level of translational errors. Curiously, Santos et al. (1996) 
observed an increase in cycloheximide resistance of a constructed S. cerevisiae 
mistranslating strain. Additionally, the deletion of the ABC pump gene PDR5 
showed decreased resistance not only to common antifungals such as FLZ but 
also to very low CHX concentrations (reviewed by Bauer et al., 1999). 
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Conclusion and Outlook 
 
Our analysis shed the first light on the understanding of the role of 
mistranslation in yeasts‟ antifungal drug response but it requires further 
investigation to draw meaningful conclusions. 
According to the Etest results, the echinocandin caspofungin (CS) was the 
most effective antifungal tested. The strains misincorporating serine at glycine, 
threonine and alanine codons seemed to have a slight advantage when exposed 
to the polyene amphotericin B (AP). The strains misincorporating serine at leucine 
and valine codons had lower MIC endpoints for both CS and AP. 
The phenomics study showed that certain types of mistranslation can be 
advantageous in terms of antifungal drug resistance. Such observation was in 
agreement with previous studies which revealed a selective advantage with other 
environmental stressors (Mateus, 2011; Santos et al., 1999). Specifically, the 
strain misincorporating serine at alanine codons showed a significant growth 
advantage in itraconazole (0.25μg/mL) supplemented media and surprisingly also 
did the strain misincorporating serine at valine codons which deals with a very 
toxic amino acid exchange. 
We verified that the mistranslating strains are in general less affected by the 
translation inhibitor cycloheximide than the control, which is in agreement with 
previous observations (Santos et al., 1996). The strain that showed the best 
growth rate is the one misicorporating serine at methionine codons. Curiously, 
none of the strains had a significantly increased relative growth rate when exposed 
to geneticin, another translation inhibitor. 
Our results together with the ones previously obtained in our laboratory, 
seem to point to the fact that S. cerevisiae does not tolerate the substitution of 
leucine by serine as well as for the other amino amino acids. Such findings are 
surprising regarding that C. albicans naturally copes with a serine-to-leucine 
ambiguity (3% leucine insertion) and even could sustain a reversion of its genetic 
code (100% leucine insertion). 
The forced evolution experiment revealed that by using miconazole, 
mistranslation did not lead to an acceleration of antifungal drug resistance in S. 
cerevisiae. 
Other surprising result verified was that, in general, the substitution of 
proline and methionine by serine did not highly affect the cell fitness. Regarding 
their chemical and structural  differences a sharp decrease in fitness would be 
expected. It would be interesting to further investigate such strains in order to 
understand the “why” and “how” of such results. 
 
In the future it could be interesting to do microarrays of cells exposed to 
several antifungal drugs in different time intervals. It was already seen that short 
time intervals can make a difference in gene expression (Kuo et al., 2010) and 
doing so, could allow us to understand which genes are really important for the cell 
in different growth stages and separate them from those that are always 
differentially expressed. 
We will do WGS of the strains grown until the 230th generation in order to 
verify changes in the genome (e.g. SNP, Indels). Another experiment could be 
done in order to check if TSM is also present in eukaryotes. Exposing the cells to 
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the same concentration of antifungal for several generations instead of increasing 
it, could allow the cells to survive for longer periods of time at reduced growth 
rates and eventually overcome that stress. WGS results might include amongst 
others, a higher mutation rate in the ergosterol pathway genes (mainly ERG3 and 
ERG11), ABC and MFS pump genes, which are directly related to antifungal drug 
response. 
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Annex I 
List of genes differentially expressed by the mistranslating strains. A 
comparison among mistranslating strains was performed by multiclass SAM 
analysis (FDR≤0.0001). Values correspond to the means of fold variation 
presented by each clone. Positive values correspond to up-regulated genes and 
negative values correspond to down-regulated genes. 
 
Systematic 
name 
Gene 
name 
tRNA
Ser
(Ala) tRNA
Ser
(Gly) tRNA
Ser
(Leu) tRNA
Ser
(Thr) tRNA
Ser
(Tyr) tRNA
Ser
(Val) 
YJR155W AAD10 -1,45 0,39 -0,53 0,82 -0,70 -0,15 
YPL267W ACM1 0,18 -0,15 -0,49 0,43 -0,16 0,02 
YAR015W ADE1 -2,05 0,55 -1,56 0,04 -1,53 0,08 
YLR359W ADE13 -2,54 0,01 -2,34 -0,01 -2,53 -0,66 
YMR120C ADE17 -2,94 0,49 -2,70 -0,03 -2,61 -0,97 
YOR128C ADE2 -1,52 0,55 -1,31 0,32 -1,45 0,15 
YMR300C ADE4 -1,44 0,31 -1,00 0,09 -1,06 0,09 
YGL234W ADE5,7 -1,91 0,03 -1,61 -0,20 -1,67 -0,50 
YGR061C ADE6 -1,54 0,01 -1,03 -0,49 -1,04 -0,58 
YDR408C ADE8 -0,88 -0,06 -0,47 -0,02 -0,58 0,06 
YMR303C ADH2 0,87 0,41 0,77 -0,32 0,55 0,53 
YGL256W ADH4 -2,73 -0,50 -3,36 -0,62 -3,82 -1,05 
YJL122W ALB1 0,50 -1,20 -0,04 0,09 -0,03 -0,25 
YER073W ALD5 0,34 -0,41 0,83 0,12 1,00 0,14 
YPL061W ALD6 0,11 -0,06 -0,12 -0,72 0,64 0,03 
YOL058W ARG1 1,10 0,17 1,59 0,62 1,96 1,37 
YHR018C ARG4 0,74 0,18 1,23 0,47 1,14 0,81 
YER069W ARG5,6 0,74 -0,03 1,14 0,43 1,42 0,71 
YOL140W ARG8 0,40 -0,48 0,58 0,24 0,79 0,23 
YDR127W ARO1 -0,08 0,04 0,84 -0,12 0,70 0,42 
YDR380W ARO10 -0,16 0,46 0,78 0,53 1,21 1,04 
YBR249C ARO4 0,52 -0,02 1,11 0,25 0,76 0,52 
YBR068C BAP2 0,22 0,08 1,01 0,23 0,87 0,47 
YDR046C BAP3 0,46 -0,17 0,47 0,12 0,64 0,49 
YKR099W BAS1 0,94 -0,30 0,42 0,61 1,00 0,09 
YHR208W BAT1 0,16 -0,01 1,06 0,20 0,70 0,48 
YLR412W BER1 0,37 -0,14 0,68 0,04 0,34 0,15 
YNR058W BIO3 -2,07 -0,35 -1,20 0,85 -0,79 -0,94 
YNR057C BIO4 -1,41 -0,07 -0,61 1,44 -0,47 -0,45 
YNR056C BIO5 -2,13 -0,10 -1,35 1,45 -0,89 -0,85 
YBL098W BNA4 -1,03 0,41 -0,25 0,01 -0,73 -0,39 
YLR231C BNA5 -0,92 -0,13 -0,12 0,08 -0,77 -0,62 
YFR047C BNA6 -0,57 0,38 -0,05 0,22 -0,44 0,00 
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YLR267W BOP2 0,70 0,68 1,32 0,30 -0,19 0,14 
YGR142W BTN2 1,37 1,08 0,86 0,33 2,22 1,64 
YPL111W CAR1 0,99 0,43 0,41 -0,46 -0,22 0,66 
YLR438W CAR2 0,89 1,39 1,45 -0,10 0,02 0,78 
YCL064C CHA1 1,26 -0,48 0,10 -0,48 1,33 0,22 
YHR122W CIA2 0,66 -0,23 0,53 0,30 0,77 0,24 
YCR005C CIT2 0,78 0,90 1,33 0,81 1,39 2,09 
YOR303W CPA1 0,92 -0,05 1,50 0,64 1,45 0,87 
YJR109C CPA2 0,58 -0,15 1,35 0,21 1,17 0,68 
YBR233W-
A 
DAD3 -0,94 1,63 1,38 0,09 0,00 0,47 
YOR173W DCS2 -0,54 1,77 1,31 0,48 0,74 0,36 
YPL265W DIP5 0,77 0,76 1,27 0,49 1,34 1,55 
YEL071W DLD3 0,73 0,31 1,00 0,43 1,03 1,22 
YIL103W DPH1 0,13 -1,10 -0,54 -0,12 -0,24 -0,25 
YKL191W DPH2 0,58 -0,68 0,00 0,22 0,43 0,00 
YBR208C DUR1,2 0,34 0,89 -0,35 -0,45 -0,51 0,25 
YGR146C ECL1 0,68 0,59 1,30 0,31 1,38 1,01 
YMR062C ECM40 0,83 0,39 1,37 0,49 1,34 1,01 
YPL095C EEB1 -0,17 0,01 -1,26 -0,53 -0,42 -0,04 
YAL003W EFB1 0,59 -0,07 -0,02 0,19 0,29 0,35 
YMR323W ERR3 0,04 0,92 0,01 0,11 0,02 0,15 
YOR388C FDH1 -0,31 0,36 0,55 5,28 0,30 0,12 
YPL276W FDH2 -0,57 -0,06 0,09 3,75 -0,47 0,02 
YPL275W p-FDH2 -0,59 0,25 0,53 4,87 -0,50 0,05 
YMR319C FET4 -0,19 0,24 -0,18 0,84 -1,33 0,16 
YDR070C FMP16 -0,21 2,40 2,27 0,90 0,86 0,24 
YBR047W FMP23 1,21 0,88 1,88 1,15 2,01 1,46 
YDL222C FMP45 -0,18 1,68 0,08 -0,13 0,18 0,03 
YLR214W FRE1 0,71 1,25 0,38 2,15 -0,92 0,35 
YOL152W FRE7 1,62 4,05 1,74 4,62 -0,50 0,52 
YBL042C FUI1 0,22 -1,60 -0,73 -0,36 -0,17 -0,51 
YDR019C GCV1 -1,73 -0,04 -1,18 -0,14 -0,81 -0,17 
YMR189W GCV2 -1,61 -0,11 -0,99 -0,15 -0,95 -0,10 
YPR184W GDB1 -0,25 1,36 1,07 0,32 0,35 0,29 
YEL011W GLC3 -0,54 1,32 0,91 -0,19 0,20 -0,04 
YKR058W GLG1 -0,82 0,89 0,40 -0,21 -0,08 0,14 
YGR256W GND2 -0,34 1,42 0,97 0,97 -0,14 -0,06 
YPR160W GPH1 -1,03 1,17 1,21 0,00 0,05 -0,12 
YDL021W GPM2 -0,97 0,70 -0,08 0,08 -0,54 -0,05 
YPL223C GRE1 -0,43 0,94 1,63 0,20 -0,12 -0,07 
YFR015C GSY1 -0,88 1,11 0,23 -0,64 -0,76 -0,36 
YJR055W HIT1 -0,28 0,68 -0,23 0,45 -0,41 -0,06 
YLR205C HMX1 0,00 0,15 1,01 -0,28 0,37 0,31 
YER052C HOM3 0,72 0,23 1,17 0,39 1,29 0,49 
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YOL155C HPF1 -1,09 0,31 -0,57 -0,14 -0,55 -0,50 
YDR399W HPT1 Nd
1
 Nd Nd Nd Nd -1,57 
YBR072W HSP26 -1,85 1,20 1,48 0,03 0,25 -0,52 
YCR021C HSP30 0,04 0,77 1,76 -0,14 1,13 0,82 
YHR096C HXT5 0,27 1,11 1,12 0,12 -0,59 0,05 
YDR342C HXT7 -0,23 0,33 0,68 0,45 0,14 -0,33 
YLR099C ICT1 0,75 0,74 1,23 0,22 0,74 0,29 
YPL250C ICY2 0,56 0,19 1,33 0,50 1,42 0,73 
YJR016C ILV3 0,40 0,03 1,06 0,21 1,05 0,25 
YCL009C ILV6 0,62 0,48 1,27 0,40 1,44 0,82 
YAR073W IMD1 0,59 -1,09 0,03 0,21 -1,00 -0,91 
YJL153C INO1 1,21 1,94 0,21 0,33 0,07 0,08 
YHR085W IPI1 0,59 -0,95 -0,06 0,40 0,15 0,17 
YMR081C ISF1 -0,93 0,56 0,83 -0,71 -0,54 0,08 
YLL019C KNS1 -0,31 0,35 0,43 -0,11 0,39 -0,03 
YKL103C LAP4 -0,22 1,06 -0,23 0,04 0,13 -0,32 
YCL018W LEU2 -1,23 -0,45 -2,07 -1,09 -1,00 -1,41 
YNL104C LEU4 0,40 0,40 1,43 0,38 1,37 0,56 
YIR034C LYS1 0,95 0,71 1,24 0,72 1,70 0,68 
YBR115C LYS2 0,54 0,30 1,24 0,34 1,31 0,67 
YDL182W LYS20 1,83 1,30 2,64 1,45 2,43 1,70 
YKL021C MAK11 0,41 -0,63 -0,17 0,08 -0,10 -0,11 
YGL125W MET13 0,58 0,84 1,38 0,47 1,61 0,54 
YML128C MSC1 -1,15 1,10 0,34 0,22 -0,15 -0,14 
YKR080W MTD1 -1,64 0,57 -1,25 0,16 -1,50 0,37 
YNL240C NAR1 0,65 -0,18 0,53 0,45 0,88 0,08 
YNL036W NCE103 0,74 0,84 1,73 0,58 1,41 1,33 
YOL144W NOP8 0,41 -0,91 -0,12 0,30 0,36 -0,18 
YKL120W OAC1 0,32 -0,12 0,99 0,24 0,81 0,65 
YPR194C OPT2 -1,49 -0,67 -0,16 -0,77 -1,16 0,40 
YOR269W PAC1 0,78 0,04 0,37 0,22 0,96 0,17 
YHR071W PCL5 1,07 0,62 1,75 0,93 1,80 1,09 
YGR239C PEX21 0,42 -0,15 0,84 0,43 0,98 0,52 
YDR281C PHM6 0,12 0,23 2,02 0,33 -0,15 -0,13 
YBR093C PHO5 -1,23 -1,06 -0,03 -0,46 -1,47 -0,92 
YML123C PHO84 -0,47 0,16 6,68 -0,62 -0,64 -0,06 
YBR296C PHO89 0,22 0,37 1,35 0,14 -0,14 0,10 
YKL163W PIR3 -0,72 -0,41 0,67 -0,85 -0,52 -0,33 
YBL018C POP8 0,36 -0,82 -0,17 -0,10 0,02 0,05 
YDR075W PPH3 0,29 -0,53 0,19 0,26 0,07 -0,04 
YJL079C PRY1 -1,00 -0,23 0,44 0,08 0,10 -0,75 
YML017W PSP2 0,05 0,02 -1,20 0,20 0,52 -0,08 
                                                          
1
 Nd – No hibridization was detected. 
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YER075C PTP3 0,57 -0,06 0,47 0,36 0,79 -0,27 
YLR142W PUT1 0,22 0,73 0,57 0,04 -0,17 0,02 
YGL062W PYC1 0,48 0,98 1,18 0,29 1,16 1,26 
YJL217W REE1 1,65 2,54 1,66 3,22 0,53 1,41 
YLR073C RFU1 0,95 -0,97 0,58 0,38 0,36 -0,22 
YER067W RGI1 -0,33 1,98 0,93 0,02 -0,07 0,64 
YBR256C RIB5 0,65 0,14 1,00 0,48 1,09 0,74 
YOR287C RRP36 0,47 -0,99 -0,26 0,24 0,11 0,01 
YIL127C RRT14 0,30 -0,85 -0,31 0,12 -0,23 -0,10 
YHR056C RSC30 -0,30 0,41 0,16 0,68 -0,07 -0,37 
YER125W RSP5 -0,52 -0,01 -0,78 -0,44 -0,03 -0,66 
YDL204W RTN2 -0,48 1,97 1,08 0,09 1,04 0,02 
YPL274W SAM3 0,42 -0,10 0,73 0,41 0,98 0,76 
YBR214W SDS24 -0,51 0,94 0,63 -0,18 0,23 0,62 
YGR208W SER2 -0,51 0,15 -0,96 -0,17 -0,90 0,00 
YER081W SER3 -0,84 1,10 -0,60 0,39 -0,88 0,20 
YLR058C SHM2 -1,52 0,10 -1,53 0,15 -1,14 -0,54 
YMR175W SIP18 -0,38 0,73 1,99 0,16 -0,08 0,00 
YMR095C SNO1 1,44 0,94 2,24 1,43 2,20 1,81 
YMR096W SNZ1 1,15 0,78 2,07 1,16 2,02 1,76 
YMR107W SPG4 0,52 1,76 1,78 0,46 -0,73 0,86 
YHR136C SPL2 -0,19 -0,19 5,15 -0,36 -0,65 -0,01 
YHR184W SSP1 -0,22 -0,19 -0,52 0,42 -0,69 -0,13 
YDL048C STP4 -0,34 -0,14 0,74 -0,29 0,78 -0,31 
YDL244W THI13 -0,05 0,38 0,56 0,57 -0,36 -0,40 
YOL055C THI20 -1,40 -0,24 -0,71 -1,08 -1,13 -0,24 
YLR327C TMA10 -0,33 1,96 1,47 0,02 0,88 0,79 
YGL026C TRP5 0,58 0,25 0,98 0,35 0,85 0,68 
YLR193C UPS1 0,07 0,14 0,90 0,09 0,44 0,07 
YKL216W URA1 0,75 -0,86 -0,36 -0,08 0,20 0,21 
YOR004W UTP23 0,23 -1,69 -0,29 0,03 -0,20 -0,30 
YGL258W VEL1 -3,79 -0,94 -4,00 0,23 -4,35 -2,09 
YIL056W VHR1 0,80 0,55 1,46 0,56 1,42 0,71 
YGR065C VHT1 -1,15 -0,01 -0,75 0,81 -0,38 -0,78 
YER072W VTC1 0,71 0,44 2,96 0,42 0,37 0,24 
YFL004W VTC2 -0,26 -0,16 0,78 -0,23 -0,17 -0,18 
YPL019C VTC3 -0,46 0,00 1,64 -0,23 -0,46 -0,12 
YJL012C VTC4 -0,20 -0,04 1,47 -0,07 -0,05 -0,23 
YER024W YAT2 0,38 0,49 1,36 0,38 1,18 0,87 
YGR234W YHB1 0,12 0,10 1,08 -0,19 1,04 0,50 
YHR029C YHI9 0,90 0,49 1,76 0,51 1,46 1,07 
YDL198C YHM1 0,55 0,08 0,95 0,29 1,18 0,59 
YPR058W YMC1 0,65 0,07 0,96 0,17 0,78 0,28 
YBR104W YMC2 0,63 -0,64 0,68 0,15 0,59 0,36 
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YGR211W ZPR1 0,63 -0,49 0,11 0,10 0,73 0,20 
YOL154W ZPS1 -2,19 -0,49 -2,79 0,31 -3,06 -0,93 
YEL073C 
 
-0,82 0,46 -0,41 -0,45 -0,83 -0,76 
YBL028C 
 
0,28 -1,21 -0,44 -0,14 -0,22 -0,70 
YLR162W 
 
-1,37 -0,28 -2,27 -1,33 -0,98 -0,05 
YDR161W 
 
0,47 -0,94 -0,08 0,11 0,00 -0,10 
YMR321C 
 
0,38 -0,37 0,53 -0,12 0,44 0,18 
YHR054C 
 
-0,43 0,41 0,25 0,58 -0,17 -0,15 
YIL165C 
 
0,65 0,17 0,92 0,43 1,26 0,56 
YGR153W 
 
-0,20 -0,33 -0,62 0,19 -0,96 0,03 
YPR074W-
A  
0,68 -1,15 -0,18 0,61 0,04 -0,08 
YJR079W 
 
-0,75 0,77 0,01 0,50 -0,49 0,06 
YBR285W 
 
-0,98 1,22 1,16 0,78 -0,37 -0,29 
YLR179C 
 
0,50 0,42 1,20 0,31 0,88 0,90 
YNL058C 
 
-0,36 -0,45 0,54 0,02 -0,27 0,21 
YGL117W 
 
1,12 0,28 1,53 0,62 1,63 1,09 
YJL012C-A 
 
-0,24 -0,10 1,58 -0,18 -0,26 -0,29 
YOR387C 
 
-3,79 -0,94 -4,16 0,17 -4,72 -1,94 
 
 
 
 
 
